809 is the total number of securities Orbimed Advisors has owned. The longest Orbimed Advisors has owned a single stock is 42 quarters.
Period | Weighting | Quarter | |||||||
---|---|---|---|---|---|---|---|---|---|
Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
BIIB | BIOGEN INC | 42 | 42 | 0.16% | 2.92% | 4.96% | Q2 2013 | Q3 2023 | 42 |
VRTX | VERTEX PHARMACEUTICALS... | 42 | 42 | 0.10% | 1.88% | 3.75% | Q2 2013 | Q3 2023 | 42 |
TMO | THERMO FISHER SCIENTIF... | 42 | 42 | 0.45% | 1.51% | 3.20% | Q2 2013 | Q3 2023 | 42 |
SVA | SINOVAC BIOTECH LTD | 35 | 6 | 0.10% | 1.21% | 7.22% | Q2 2013 | Q3 2023 | 41 |
NBIX | NEUROCRINE BIOSCIENCES... | 23 | 18 | 0.08% | 1.12% | 2.69% | Q2 2013 | Q3 2023 | 41 |
BSX | BOSTON SCIENTIFIC CORP | 39 | 1 | 0.03% | 3.04% | 5.64% | Q3 2013 | Q3 2023 | 40 |
BMY | BRISTOL-MYERS SQUIBB CO | 25 | 15 | 0.49% | 2.77% | 5.23% | Q2 2013 | Q2 2023 | 40 |
AMGN | AMGEN INC | 37 | 3 | 0.13% | 2.03% | 5.48% | Q2 2013 | Q3 2023 | 40 |
ISRG | INTUITIVE SURGICAL INC | 40 | 40 | 0.42% | 1.54% | 3.84% | Q4 2013 | Q3 2023 | 40 |
GILD | GILEAD SCIENCES INC | 37 | 2 | 0.10% | 1.60% | 5.51% | Q2 2013 | Q3 2023 | 39 |
SYK | STRYKER CORPORATION | 25 | 1 | 0.08% | 0.76% | 2.25% | Q2 2013 | Q3 2023 | 39 |
MRK | MERCK & CO INC NEW | 24 | 1 | 0.12% | 2.53% | 5.16% | Q2 2013 | Q3 2023 | 35 |
REGN | REGENERON PHARMACEUTICALS | 29 | 1 | 0.09% | 1.61% | 4.11% | Q2 2013 | Q3 2023 | 34 |
ALXN | ALEXION PHARMACEUTICAL... | 33 | 33 | 0.15% | 2.75% | 5.28% | Q2 2013 | Q2 2021 | 33 |
UNH | UNITEDHEALTH GROUP INC | 14 | 3 | 0.10% | 1.19% | 3.86% | Q2 2013 | Q3 2023 | 33 |
BMRN | BIOMARIN PHARMACEUTICA... | 17 | 2 | 0.04% | 1.13% | 3.20% | Q2 2013 | Q3 2023 | 33 |
NTRA | NATERA INC | 33 | 33 | 0.12% | 0.92% | 2.36% | Q3 2015 | Q3 2023 | 33 |
ABBV | ABBVIE INC | 20 | 1 | 0.29% | 2.19% | 4.44% | Q2 2013 | Q3 2023 | 32 |
EW | EDWARDS LIFESCIENCES CORP | 30 | 2 | 0.06% | 1.32% | 2.28% | Q2 2013 | Q2 2023 | 32 |
CRVS | CORVUS PHARMACEUTICALS... | 31 | 31 | 0.10% | 0.47% | 1.27% | Q1 2016 | Q3 2023 | 31 |
PFE | PFIZER INC | 23 | 1 | 0.36% | 1.39% | 3.28% | Q2 2013 | Q4 2022 | 30 |
FLDM | FLUIDIGM CORP DEL | 22 | 7 | 0.07% | 0.32% | 0.81% | Q2 2013 | Q4 2021 | 29 |
XENE | XENON PHARMACEUTICALS INC | 29 | 29 | 0.02% | 0.29% | 0.87% | Q3 2016 | Q3 2023 | 29 |
SNDX | SYNDAX PHARMACEUTICALS... | 20 | 9 | 0.02% | 0.26% | 0.98% | Q1 2016 | Q3 2023 | 29 |
MRTX | MIRATI THERAPEUTICS INC | 17 | 11 | 0.01% | 1.19% | 2.75% | Q3 2013 | Q3 2023 | 28 |
AGLE | AEGLEA BIOTHERAPEUTICS... | 28 | 28 | 0.01% | 0.19% | 0.52% | Q2 2016 | Q1 2023 | 28 |
HUM | HUMANA INC | 17 | 4 | 0.26% | 1.79% | 3.54% | Q1 2016 | Q3 2023 | 27 |
ILMN | ILLUMINA INC | 25 | 2 | 0.22% | 1.44% | 2.91% | Q2 2013 | Q1 2022 | 27 |
ASND | ASCENDIS PHARMA A/S | 26 | 26 | 0.04% | 2.36% | 7.24% | Q1 2015 | Q2 2021 | 26 |
HCA | HCA HOLDINGS INC | 18 | 2 | 0.13% | 1.99% | 4.71% | Q2 2013 | Q4 2021 | 26 |
IOVA | IOVANCE BIOTHERAPEUTIC... | 26 | 26 | 0.24% | 1.33% | 2.79% | Q2 2017 | Q3 2023 | 26 |
SRPT | SAREPTA THERAPEUTICS INC | 24 | 1 | 0.03% | 0.97% | 2.41% | Q3 2016 | Q3 2023 | 26 |
VRNA | VERONA PHARMA PLC | 26 | 26 | 0.08% | 0.50% | 2.29% | Q2 2017 | Q3 2023 | 26 |
A | AGILENT TECHNOLOGIES INC | 25 | 25 | 0.92% | 1.71% | 2.54% | Q2 2013 | Q2 2019 | 25 |
ALPN | ALPINE IMMUNE SCIENCES... | 25 | 25 | 0.18% | 0.44% | 0.99% | Q3 2017 | Q3 2023 | 25 |
BLRX | BIOLINERX LTD | 25 | 25 | 0.01% | 0.02% | 0.06% | Q2 2013 | Q2 2019 | 25 |
CELG | CELGENE CORP | 24 | 24 | 0.43% | 3.42% | 4.67% | Q2 2013 | Q1 2019 | 24 |
EHTH | EHEALTH INC | 24 | 24 | 0.02% | 0.57% | 1.52% | Q1 2015 | Q4 2020 | 24 |
SCPH | SCPHARMACEUTICALS INC | 24 | 24 | 0.16% | 0.44% | 1.03% | Q4 2017 | Q3 2023 | 24 |
SYBX | SYNLOGIC INC | 24 | 24 | 0.04% | 0.15% | 0.35% | Q3 2017 | Q2 2023 | 24 |
PBYI | PUMA BIOTECHNOLOGY INC | 22 | 1 | 0.12% | 1.16% | 2.78% | Q2 2013 | Q3 2019 | 23 |
XTNT | XTANT MED HLDGS INC | 23 | 23 | 0.10% | 0.71% | 1.71% | Q1 2018 | Q3 2023 | 23 |
ABT | ABBOTT LABS | 15 | 8 | 0.08% | 0.33% | 1.31% | Q2 2013 | Q4 2019 | 23 |
JNJ | JOHNSON & JOHNSON | 22 | 22 | 0.27% | 0.80% | 1.56% | Q2 2013 | Q3 2018 | 22 |
ARRY | ARRAY BIOPHARMA INC | 22 | 22 | 0.24% | 0.76% | 1.80% | Q2 2013 | Q3 2018 | 22 |
ZBH | ZIMMER HLDGS INC | 18 | 1 | 0.06% | 0.62% | 1.44% | Q2 2013 | Q2 2023 | 22 |
JAZZ | JAZZ PHARMACEUTICALS PLC | 22 | 22 | 0.10% | 0.56% | 2.14% | Q2 2013 | Q3 2018 | 22 |
AMRN | AMARIN CORP PLC | 17 | 5 | 0.00% | 0.04% | 0.22% | Q2 2013 | Q4 2019 | 22 |
ICPT | INTERCEPT PHARMACEUTIC... | 18 | 1 | 0.04% | 1.98% | 7.04% | Q2 2013 | Q4 2019 | 21 |
CRNX | CRINETICS PHARMACEUTIC... | 21 | 21 | 0.34% | 0.87% | 1.83% | Q3 2018 | Q3 2023 | 21 |
QURE | UNIQURE NV | 18 | 3 | 0.02% | 0.44% | 1.11% | Q1 2016 | Q3 2023 | 21 |
NTLA | INTELLIA THERAPEUTICS INC | 17 | 1 | 0.04% | 0.25% | 0.63% | Q2 2016 | Q1 2023 | 21 |
INCY | INCYTE CORP | 18 | 1 | 0.07% | 2.13% | 3.05% | Q2 2013 | Q4 2019 | 20 |
SHPG | SHIRE PLC | 20 | 20 | 0.47% | 1.56% | 3.30% | Q3 2013 | Q2 2018 | 20 |
IRWD | IRONWOOD PHARMACEUTICA... | 20 | 20 | 0.16% | 1.14% | 1.80% | Q1 2014 | Q4 2018 | 20 |
AET | AETNA INC NEW | 19 | 1 | 0.06% | 0.70% | 2.12% | Q2 2013 | Q3 2018 | 20 |
IMGN | IMMUNOGEN INC | 14 | 1 | 0.02% | 0.36% | 0.93% | Q2 2015 | Q4 2021 | 20 |
PRQR | PROQR THRAPEUTICS N V | 20 | 20 | 0.05% | 0.21% | 0.48% | Q3 2014 | Q2 2019 | 20 |
SELB | SELECTA BIOSCIENCES INC | 20 | 20 | 0.01% | 0.19% | 0.40% | Q2 2016 | Q1 2021 | 20 |
ADAP | ADAPTIMMUNE THERAPEUTI... | 20 | 20 | 0.02% | 0.11% | 0.59% | Q2 2015 | Q1 2020 | 20 |
RDHL | REDHILL BIOPHARMA LTD | 20 | 20 | 0.01% | 0.07% | 0.12% | Q1 2014 | Q4 2018 | 20 |
ALIM | ALIMERA SCIENCES INC | 20 | 20 | 0.00% | 0.03% | 0.15% | Q1 2014 | Q4 2018 | 20 |
SIBN | SI-BONE INC | 15 | 4 | 0.14% | 0.61% | 1.15% | Q4 2018 | Q3 2023 | 19 |
ARGX | ARGENX SE | 12 | 7 | 0.06% | 0.59% | 1.77% | Q2 2017 | Q3 2023 | 19 |
GLPG | GALAPAGOS NV | 14 | 5 | 0.10% | 0.32% | 0.60% | Q2 2015 | Q1 2022 | 19 |
OTIC | OTONOMY INC | 13 | 2 | 0.00% | 0.30% | 0.72% | Q3 2014 | Q2 2021 | 19 |
VRX | VALEANT PHARMACEUTICAL... | 19 | 19 | 0.02% | 0.16% | 0.36% | Q2 2013 | Q4 2017 | 19 |
XNCR | XENCOR INC | 18 | 1 | 0.01% | 0.16% | 0.28% | Q4 2013 | Q3 2023 | 19 |
XFOR | X4 PHARMACEUTICALS INC | 19 | 19 | 0.02% | 0.12% | 0.25% | Q1 2019 | Q3 2023 | 19 |
FLUIDIGM CORP DEL | 19 | 19 | 0.06% | 0.11% | 0.25% | Q1 2014 | Q3 2018 | 19 | |
BIOMARIN PHARMACEUTICA... | 17 | 2 | 0.01% | 0.01% | 0.01% | Q4 2013 | Q3 2018 | 19 | |
BIOMARIN PHARMACEUTICA... | 17 | 2 | 0.01% | 0.01% | 0.01% | Q4 2013 | Q3 2018 | 19 | |
TCDA | TRICIDA INC | 18 | 18 | 0.42% | 3.02% | 6.79% | Q2 2018 | Q3 2022 | 18 |
MOH | MOLINA HEALTHCARE INC | 11 | 2 | 0.30% | 1.14% | 2.25% | Q2 2013 | Q1 2021 | 18 |
BLUE | BLUEBIRD BIO INC | 16 | 1 | 0.08% | 0.61% | 1.18% | Q3 2013 | Q4 2018 | 18 |
NXTC | NEXTCURE INC | 18 | 18 | 0.07% | 0.51% | 2.18% | Q2 2019 | Q3 2023 | 18 |
INFI | INFINITY PHARMACEUTICA... | 18 | 18 | 0.03% | 0.49% | 1.55% | Q2 2013 | Q3 2017 | 18 |
MRSN | MERSANA THERAPEUTICS INC | 18 | 18 | 0.06% | 0.41% | 1.13% | Q1 2019 | Q2 2023 | 18 |
HARP | HARPOON THERAPEUTICS INC | 18 | 18 | 0.01% | 0.30% | 0.63% | Q1 2019 | Q2 2023 | 18 |
ASMB | ASSEMBLY BIOSCIENCES INC | 18 | 18 | 0.07% | 0.26% | 0.69% | Q1 2015 | Q2 2019 | 18 |
CTIC | CTI BIOPHARMA CORP | 18 | 18 | 0.07% | 0.17% | 0.30% | Q2 2017 | Q3 2021 | 18 |
AFMD | AFFIMED THERAPEUTICS B V | 18 | 18 | 0.01% | 0.15% | 0.58% | Q3 2014 | Q4 2018 | 18 |
SWTX | SPRINGWORKS THERAPEUTI... | 17 | 17 | 1.95% | 3.66% | 5.52% | Q3 2019 | Q3 2023 | 17 |
ANTM | ANTHEM INC | 7 | 1 | 0.17% | 1.31% | 1.88% | Q4 2014 | Q3 2021 | 17 |
DCPH | DECIPHERA PHARMACEUTIC... | 17 | 17 | 0.07% | 0.87% | 1.58% | Q3 2017 | Q3 2021 | 17 |
LOXO | LOXO ONCOLOGY INC | 17 | 17 | 0.23% | 0.72% | 1.52% | Q3 2014 | Q3 2018 | 17 |
IMMU | IMMUNOMEDICS INC | 16 | 1 | 0.06% | 0.64% | 1.73% | Q3 2015 | Q2 2020 | 17 |
INSYQ | INSYS THERAPEUTICS INC... | 17 | 17 | 0.26% | 0.64% | 1.17% | Q3 2014 | Q3 2018 | 17 |
MGTX | MEIRAGTX HOLDINGS PLC | 17 | 17 | 0.04% | 0.64% | 1.14% | Q3 2018 | Q3 2022 | 17 |
TEVA | TEVA PHARMACEUTICAL IN... | 13 | 1 | 0.07% | 0.61% | 1.52% | Q3 2014 | Q4 2020 | 17 |
INSM | INSMED INC | 14 | 1 | 0.02% | 0.56% | 0.96% | Q2 2014 | Q4 2019 | 17 |
KALA | KALA PHARMACEUTICALS INC | 17 | 17 | 0.10% | 0.44% | 0.80% | Q3 2017 | Q3 2021 | 17 |
GWPH | GW PHARMACEUTICALS PLC | 9 | 1 | 0.04% | 0.25% | 0.65% | Q4 2013 | Q3 2018 | 17 |
HRTX | HERON THERAPEUTICS INC | 9 | 1 | 0.02% | 0.23% | 0.67% | Q1 2017 | Q3 2023 | 17 |
NVTA | INVITAE CORP | 17 | 17 | 0.03% | 0.09% | 0.26% | Q1 2015 | Q1 2019 | 17 |
WMGI | WRIGHT MED GROUP N V | 16 | 16 | 1.19% | 2.03% | 3.16% | Q4 2015 | Q3 2019 | 16 |
LLY | LILLY ELI & CO | 10 | 3 | 0.08% | 1.65% | 3.18% | Q1 2014 | Q3 2023 | 16 |
THC | TENET HEALTHCARE CORP | 9 | 1 | 0.15% | 0.78% | 1.71% | Q2 2016 | Q3 2023 | 16 |
MGLN | MAGELLAN HEALTH INC | 16 | 16 | 0.23% | 0.78% | 1.36% | Q3 2014 | Q2 2018 | 16 |
LOGC | LOGICBIO THERAPEUTICS INC | 16 | 16 | 0.04% | 0.62% | 1.33% | Q4 2018 | Q3 2022 | 16 |
TELA | TELA BIO INC | 16 | 16 | 0.38% | 0.51% | 0.67% | Q4 2019 | Q3 2023 | 16 |
CRSP | CRISPR THERAPEUTICS AG | 9 | 3 | 0.06% | 0.42% | 0.85% | Q4 2016 | Q3 2021 | 16 |
AUPH | AURINIA PHARMACEUTICAL... | 10 | 6 | 0.01% | 0.36% | 0.88% | Q1 2017 | Q2 2021 | 16 |
NUVA | NUVASIVE INC | 16 | 16 | 0.05% | 0.31% | 0.76% | Q1 2014 | Q4 2017 | 16 |
PHGE | BIOMX INC | 16 | 16 | 0.01% | 0.11% | 0.32% | Q4 2019 | Q3 2023 | 16 |
AGN | ALLERGAN PLC | 15 | 15 | 0.59% | 2.38% | 4.44% | Q2 2015 | Q4 2018 | 15 |
HZNP | HORIZON THERAPEUTICS P... | 11 | 4 | 0.37% | 2.00% | 3.75% | Q4 2019 | Q3 2023 | 15 |
ARQT | ARCUTIS BIOTHERAPEUTIC... | 15 | 15 | 0.22% | 1.36% | 2.34% | Q1 2020 | Q3 2023 | 15 |
CLVS | CLOVIS ONCOLOGY INC | 9 | 6 | 0.13% | 0.98% | 2.06% | Q4 2014 | Q2 2019 | 15 |
PASG | PASSAGE BIO INC | 15 | 15 | 0.14% | 0.82% | 2.68% | Q1 2020 | Q3 2023 | 15 |
BLU | BELLUS HEALTH INC NEW | 15 | 15 | 0.11% | 0.48% | 1.17% | Q3 2019 | Q1 2023 | 15 |
EXAS | EXACT SCIENCES CORP | 10 | 5 | 0.13% | 0.45% | 1.39% | Q2 2013 | Q1 2017 | 15 |
OBSV | OBSEVA SA | 15 | 15 | 0.04% | 0.34% | 0.61% | Q1 2017 | Q3 2020 | 15 |
PTLA | PORTOLA PHARMACEUTICAL... | 15 | 15 | 0.09% | 0.27% | 0.61% | Q2 2013 | Q4 2016 | 15 |
MRNS | MARINUS PHARMACEUTICAL... | 15 | 15 | 0.01% | 0.03% | 0.07% | Q4 2015 | Q2 2019 | 15 |
IPXL | IMPAX LABORATORIES INC | 14 | 14 | 1.02% | 1.88% | 2.67% | Q2 2013 | Q3 2016 | 14 |
ESRX | EXPRESS SCRIPTS HLDG CO | 14 | 14 | 0.88% | 1.56% | 2.50% | Q2 2013 | Q3 2016 | 14 |
KROS | KEROS THERAPEUTICS INC | 14 | 14 | 0.72% | 1.07% | 1.54% | Q2 2020 | Q3 2023 | 14 |
DXCM | DEXCOM INC | 14 | 14 | 0.26% | 0.99% | 1.53% | Q4 2018 | Q1 2022 | 14 |
RPTX | REPARE THERAPEUTICS INC | 14 | 14 | 0.64% | 0.94% | 1.50% | Q2 2020 | Q3 2023 | 14 |
EXEL | EXELIXIS INC | 10 | 1 | 0.13% | 0.85% | 1.31% | Q3 2013 | Q3 2020 | 14 |
MCK | MCKESSON CORP | 13 | 1 | 0.08% | 0.83% | 1.47% | Q2 2013 | Q3 2018 | 14 |
GKOS | GLAUKOS CORP | 11 | 3 | 0.26% | 0.73% | 1.20% | Q2 2015 | Q2 2020 | 14 |
VRAY | VIEWRAY INC | 14 | 14 | 0.34% | 0.63% | 1.11% | Q1 2016 | Q2 2019 | 14 |
ACHN | ACHILLION PHARMACEUTIC... | 10 | 1 | 0.01% | 0.52% | 1.21% | Q2 2013 | Q4 2017 | 14 |
PCVX | VAXCYTE INC | 14 | 14 | 0.12% | 0.51% | 1.18% | Q2 2020 | Q3 2023 | 14 |
ORIC | ORIC PHARMACEUTICALS INC | 14 | 14 | 0.12% | 0.44% | 1.39% | Q2 2020 | Q3 2023 | 14 |
TSRO | TESARO INC | 6 | 1 | 0.03% | 0.39% | 1.01% | Q1 2014 | Q3 2018 | 14 |
FUSN | FUSION PHARMACEUTICALS... | 14 | 14 | 0.15% | 0.30% | 0.79% | Q2 2020 | Q3 2023 | 14 |
VRCA | VERRICA PHARMACEUTICAL... | 14 | 14 | 0.14% | 0.25% | 0.41% | Q2 2018 | Q3 2021 | 14 |
PIRS | PIERIS PHARMACEUTICALS... | 14 | 14 | 0.12% | 0.25% | 0.69% | Q2 2015 | Q3 2018 | 14 |
NABRIVA THERAPEUTICS PLC | 14 | 14 | 0.02% | 0.17% | 0.43% | Q2 2017 | Q3 2020 | 14 | |
NVUS | NOVUS THERAPEUTICS INC | 14 | 14 | 0.02% | 0.14% | 0.68% | Q2 2017 | Q3 2020 | 14 |
PTX | PERNIX THERAPEUTICS HL... | 14 | 14 | 0.01% | 0.08% | 0.18% | Q2 2013 | Q3 2016 | 14 |
PRLD | PRELUDE THERAPEUTICS INC | 13 | 13 | 0.72% | 2.68% | 9.76% | Q3 2020 | Q3 2023 | 13 |
TPTX | TURNING POINT THERAPEU... | 13 | 13 | 0.88% | 2.08% | 3.01% | Q2 2019 | Q2 2022 | 13 |
PMVP | PMV PHARMACEUTICALS INC | 13 | 13 | 0.62% | 1.95% | 3.95% | Q3 2020 | Q3 2023 | 13 |
ACET | ADICET BIO INC | 13 | 13 | 0.24% | 1.14% | 2.41% | Q3 2020 | Q3 2023 | 13 |
BOLD | AUDENTES THERAPEUTICS INC | 13 | 13 | 0.75% | 1.07% | 1.63% | Q3 2016 | Q3 2019 | 13 |
ETNB | 89BIO INC | 13 | 13 | 0.21% | 0.85% | 1.70% | Q4 2019 | Q4 2022 | 13 |
MNKKQ | MALLINCKRODT PUB LTD CO | 13 | 13 | 0.28% | 0.73% | 0.94% | Q3 2014 | Q3 2017 | 13 |
AFIB | ACUTUS MED INC | 13 | 13 | 0.04% | 0.44% | 2.05% | Q3 2020 | Q3 2023 | 13 |
DVA | DAVITA INC | 8 | 5 | 0.05% | 0.43% | 1.40% | Q2 2013 | Q4 2018 | 13 |
ACAD | ACADIA PHARMACEUTICALS... | 3 | 1 | 0.04% | 0.30% | 0.93% | Q2 2013 | Q4 2020 | 13 |
NVO | NOVO-NORDISK A S | 13 | 13 | 0.15% | 0.25% | 0.33% | Q3 2017 | Q3 2020 | 13 |
BMY | BRISTOL MYERS SQUIBB CO | 4 | 1 | 0.06% | 0.25% | 0.55% | Q2 2013 | Q2 2019 | 13 |
CAH | CARDINAL HEALTH INC | 13 | 13 | 0.09% | 0.22% | 0.74% | Q2 2013 | Q2 2016 | 13 |
ARPO | AERPIO PHARMACEUTICALS... | 13 | 13 | 0.04% | 0.10% | 0.26% | Q2 2018 | Q2 2021 | 13 |
TARA | PROTARA THERAPEUTICS INC | 13 | 13 | 0.03% | 0.06% | 0.10% | Q3 2020 | Q3 2023 | 13 |
MDVN | MEDIVATION INC | 9 | 3 | 0.07% | 1.76% | 2.93% | Q2 2013 | Q2 2016 | 12 |
SBTX | SILVERBACK THERAPEUTIC... | 12 | 12 | 0.50% | 1.49% | 3.57% | Q4 2020 | Q3 2023 | 12 |
MYL | MYLAN N V | 10 | 2 | 0.03% | 1.22% | 2.13% | Q4 2015 | Q2 2019 | 12 |
ABCL | ABCELLERA BIOLOGICS INC | 12 | 12 | 0.41% | 1.10% | 2.96% | Q4 2020 | Q3 2023 | 12 |
CI | CIGNA CORPORATION | 6 | 2 | 0.37% | 1.03% | 2.49% | Q2 2013 | Q3 2018 | 12 |
KNTE | KINNATE BIOPHARMA INC | 12 | 12 | 0.24% | 0.80% | 1.34% | Q4 2020 | Q3 2023 | 12 |
XBI | SPDR SER TR | 8 | 2 | 0.11% | 0.54% | 1.47% | Q1 2016 | Q1 2023 | 12 |
SPY | SPDR S&P 500 ETF TR | 7 | 1 | 0.01% | 0.51% | 1.02% | Q2 2013 | Q1 2020 | 12 |
ATNX | ATHENEX INC | 12 | 12 | 0.08% | 0.44% | 1.18% | Q1 2018 | Q4 2020 | 12 |
IMRA | IMARA INC | 12 | 12 | 0.10% | 0.38% | 1.06% | Q1 2020 | Q4 2022 | 12 |
APLT | APPLIED THERAPEUTICS INC | 9 | 3 | 0.04% | 0.35% | 0.72% | Q4 2019 | Q4 2022 | 12 |
XNPT | XENOPORT INC | 12 | 12 | 0.20% | 0.34% | 0.46% | Q2 2013 | Q1 2016 | 12 |
ALXO | ALX ONCOLOGY HLDGS INC | 12 | 12 | 0.06% | 0.25% | 0.62% | Q4 2020 | Q3 2023 | 12 |
GLTO | GALECTO INC | 12 | 12 | 0.01% | 0.17% | 0.45% | Q4 2020 | Q3 2023 | 12 |
EWTX | EDGEWISE THERAPEUTICS INC | 11 | 11 | 1.77% | 2.51% | 4.24% | Q1 2021 | Q3 2023 | 11 |
RLYP | RELYPSA INC | 11 | 11 | 1.06% | 2.27% | 3.65% | Q4 2013 | Q2 2016 | 11 |
PRELUDE THERAPEUTICS INC | 11 | 11 | 0.96% | 1.71% | 3.94% | Q1 2021 | Q3 2023 | 11 | |
HNT | HEALTH NET INC | 11 | 11 | 0.44% | 1.39% | 2.07% | Q2 2013 | Q4 2015 | 11 |
COO | COOPER COS INC | 11 | 11 | 0.43% | 1.33% | 2.06% | Q3 2014 | Q1 2017 | 11 |
GH | GUARDANT HEALTH INC | 9 | 2 | 0.22% | 1.19% | 1.82% | Q4 2018 | Q3 2022 | 11 |
AERI | AERIE PHARMACEUTICALS INC | 11 | 11 | 0.04% | 0.80% | 1.52% | Q3 2016 | Q1 2019 | 11 |
TERN | TERNS PHARMACEUTICALS INC | 11 | 11 | 0.17% | 0.77% | 1.77% | Q1 2021 | Q3 2023 | 11 |
GRCL | GRACELL BIOTECHNOLOGIE... | 11 | 11 | 0.30% | 0.68% | 1.20% | Q1 2021 | Q3 2023 | 11 |
AFFX | AFFYMETRIX INC | 11 | 11 | 0.55% | 0.67% | 0.86% | Q2 2013 | Q4 2015 | 11 |
SEM | SELECT MED HLDGS CORP | 8 | 3 | 0.14% | 0.65% | 1.13% | Q4 2016 | Q4 2021 | 11 |
BGNE | BEIGENE LTD | 10 | 1 | 0.00% | 0.64% | 1.30% | Q2 2016 | Q1 2019 | 11 |
MDT | MEDTRONIC PLC | 11 | 11 | 0.26% | 0.56% | 0.82% | Q2 2015 | Q4 2017 | 11 |
SGYPQ | SYNERGY PHARMACEUTICAL... | 11 | 11 | 0.07% | 0.47% | 1.42% | Q1 2015 | Q3 2017 | 11 |
ZLAB | ZAI LAB LTD | 11 | 11 | 0.17% | 0.39% | 0.75% | Q3 2017 | Q1 2020 | 11 |
IKNA | IKENA ONCOLOGY INC | 11 | 11 | 0.15% | 0.35% | 0.78% | Q1 2021 | Q3 2023 | 11 |
CERS | CERUS CORP | 11 | 11 | 0.04% | 0.28% | 0.42% | Q3 2013 | Q1 2016 | 11 |
ARQL | ARQULE INC | 8 | 3 | 0.07% | 0.28% | 1.42% | Q2 2013 | Q4 2019 | 11 |
CMMB | CHEMOMAB THERAPEUTICS LTD | 11 | 11 | 0.04% | 0.23% | 0.69% | Q1 2021 | Q3 2023 | 11 |
SIEN | SIENTRA INC | 11 | 11 | 0.05% | 0.22% | 0.59% | Q4 2014 | Q2 2017 | 11 |
CGEM | CULLINAN ONCOLOGY INC | 11 | 11 | 0.10% | 0.19% | 0.45% | Q1 2021 | Q3 2023 | 11 |
AVRO | AVROBIO INC | 11 | 11 | 0.03% | 0.12% | 0.20% | Q2 2018 | Q4 2020 | 11 |
EPIX | ESSA PHARMA INC | 6 | 5 | 0.02% | 0.07% | 0.13% | Q3 2019 | Q3 2023 | 11 |
ALEC | ALECTOR INC | 10 | 10 | 0.12% | 2.02% | 3.88% | Q1 2019 | Q2 2021 | 10 |
PTCT | PTC THERAPEUTICS INC | 7 | 1 | 0.03% | 0.77% | 1.46% | Q1 2014 | Q1 2020 | 10 |
JANX | JANUX THERAPEUTICS INC | 10 | 10 | 0.61% | 0.71% | 0.88% | Q2 2021 | Q3 2023 | 10 |
TBPH | THERAVANCE BIOPHARMA INC | 10 | 10 | 0.08% | 0.69% | 1.19% | Q1 2020 | Q2 2022 | 10 |
OPHT | OPHTHOTECH CORP | 9 | 1 | 0.02% | 0.67% | 1.43% | Q4 2013 | Q3 2016 | 10 |
PGNY | PROGYNY INC | 6 | 4 | 0.12% | 0.61% | 0.82% | Q2 2020 | Q1 2023 | 10 |
BNR | BURNING ROCK BIOTECH LTD | 10 | 10 | 0.06% | 0.61% | 1.80% | Q2 2020 | Q3 2022 | 10 |
SRRA | SIERRA ONCOLOGY INC | 10 | 10 | 0.20% | 0.52% | 1.96% | Q1 2020 | Q2 2022 | 10 |
TORC | RESTORBIO INC | 10 | 10 | 0.08% | 0.52% | 0.88% | Q1 2018 | Q2 2020 | 10 |
PRTA | PROTHENA CORP PLC | 8 | 2 | 0.19% | 0.51% | 0.89% | Q4 2013 | Q4 2020 | 10 |
NPCE | NEUROPACE INC | 10 | 10 | 0.11% | 0.50% | 0.96% | Q2 2021 | Q3 2023 | 10 |
FOLD | AMICUS THERAPEUTICS INC | 7 | 3 | 0.06% | 0.50% | 1.32% | Q4 2017 | Q2 2023 | 10 |
KDNY | CHINOOK THERAPEUTICS INC | 10 | 10 | 0.17% | 0.47% | 1.02% | Q4 2020 | Q1 2023 | 10 |
DBTX | DECIBEL THERAPEUTICS INC | 10 | 10 | 0.19% | 0.34% | 0.52% | Q1 2021 | Q2 2023 | 10 |
GRAY | GRAYBUG VISION INC | 10 | 10 | 0.04% | 0.28% | 1.14% | Q3 2020 | Q4 2022 | 10 |
NLNK | NEWLINK GENETICS CORP | 9 | 1 | 0.08% | 0.25% | 0.54% | Q1 2015 | Q3 2017 | 10 |
AVTE | AEROVATE THERAPEUTICS INC | 10 | 10 | 0.08% | 0.20% | 0.43% | Q2 2021 | Q3 2023 | 10 |
CRIS | CURIS INC | 10 | 10 | 0.02% | 0.17% | 0.46% | Q3 2019 | Q4 2021 | 10 |
OMIC | SINGULAR GENOMICS SYST... | 10 | 10 | 0.00% | 0.15% | 0.56% | Q2 2021 | Q3 2023 | 10 |
ALKS | ALKERMES PLC | 7 | 1 | 0.07% | 0.10% | 0.26% | Q2 2014 | Q2 2023 | 10 |
AEGERION PHARMACEUTICA... | 10 | 10 | 0.02% | 0.09% | 0.15% | Q4 2016 | Q1 2019 | 10 | |
CLLS | CELLECTIS S A | 10 | 10 | 0.02% | 0.09% | 0.10% | Q1 2015 | Q2 2017 | 10 |
FATE | FATE THERAPEUTICS INC | 10 | 10 | 0.01% | 0.04% | 0.08% | Q4 2013 | Q1 2016 | 10 |
QLTI | QLT INC | 6 | 4 | 0.01% | 0.02% | 0.05% | Q2 2013 | Q3 2016 | 10 |
XTNT | XTANT MEDICAL HOLDINGS... | 10 | 10 | 0.00% | 0.01% | 0.02% | Q3 2015 | Q4 2017 | 10 |
INSP | INSPIRE MED SYS INC | 9 | 9 | 0.35% | 1.14% | 1.70% | Q2 2018 | Q2 2020 | 9 |
EVH | EVOLENT HEALTH INC | 9 | 9 | 0.12% | 1.13% | 1.84% | Q3 2021 | Q3 2023 | 9 |
CI | THE CIGNA GROUP | 7 | 2 | 0.62% | 1.10% | 1.70% | Q4 2018 | Q3 2023 | 9 |
PODD | INSULET CORP | 9 | 9 | 0.10% | 1.09% | 2.03% | Q2 2013 | Q2 2015 | 9 |
CNC | CENTENE CORP DEL | 4 | 1 | 0.46% | 0.92% | 1.34% | Q2 2013 | Q4 2020 | 9 |
VECT | VECTIVBIO HLDG AG | 9 | 9 | 0.33% | 0.75% | 1.59% | Q2 2021 | Q2 2023 | 9 |
GBT | GLOBAL BLOOD THERAPEUT... | 7 | 2 | 0.14% | 0.69% | 1.18% | Q1 2017 | Q2 2022 | 9 |
ADVM | ADVERUM BIOTECHNOLOGIE... | 9 | 9 | 0.10% | 0.53% | 0.97% | Q1 2019 | Q1 2021 | 9 |
NSTG | NANOSTRING TECHNOLOGIE... | 9 | 9 | 0.29% | 0.52% | 0.95% | Q1 2020 | Q1 2022 | 9 |
INVIVYD INC | 9 | 9 | 0.10% | 0.50% | 2.50% | Q3 2021 | Q3 2023 | 9 | |
OSUR | ORASURE TECHNOLOGIES INC | 9 | 9 | 0.06% | 0.36% | 0.54% | Q2 2013 | Q2 2015 | 9 |
GHRS | GH RESEARCH PLC | 9 | 9 | 0.16% | 0.32% | 0.43% | Q2 2021 | Q2 2023 | 9 |
INCYTE CORP | 9 | 9 | 0.20% | 0.32% | 0.42% | Q2 2013 | Q2 2015 | 9 | |
DERM | DERMIRA INC | 6 | 3 | 0.11% | 0.26% | 0.43% | Q3 2016 | Q4 2018 | 9 |
CHRS | COHERUS BIOSCIENCES INC | 9 | 9 | 0.14% | 0.22% | 0.34% | Q3 2016 | Q3 2018 | 9 |
FWP | FORWARD PHARMA A/S | 9 | 9 | 0.14% | 0.19% | 0.27% | Q4 2014 | Q4 2016 | 9 |
LBIO | LION BIOTECHNOLOGIES INC | 9 | 9 | 0.06% | 0.17% | 0.32% | Q1 2015 | Q1 2017 | 9 |
DBVT | DBV TECHNOLOGIES S A | 9 | 9 | 0.09% | 0.16% | 0.21% | Q3 2016 | Q3 2018 | 9 |
FLXN | FLEXION THERAPEUTICS INC | 8 | 1 | 0.02% | 0.16% | 0.31% | Q2 2019 | Q3 2021 | 9 |
NMTR | 9 METERS BIOPHARMA INC | 9 | 9 | 0.04% | 0.16% | 0.28% | Q2 2020 | Q2 2022 | 9 |
MIST | MILESTONE PHARMACEUTIC... | 8 | 1 | 0.04% | 0.16% | 0.27% | Q4 2019 | Q2 2022 | 9 |
ROKA | ROKA BIOSCIENCE INC | 9 | 9 | 0.02% | 0.09% | 0.34% | Q3 2014 | Q3 2016 | 9 |
INCYTE CORP | 9 | 9 | 0.06% | 0.08% | 0.11% | Q4 2014 | Q4 2016 | 9 | |
INCYTE CORP | 9 | 9 | 0.06% | 0.08% | 0.11% | Q4 2014 | Q4 2016 | 9 | |
INOTEK PHARMACEUTICALS... | 9 | 9 | 0.04% | 0.08% | 0.11% | Q3 2016 | Q3 2018 | 9 | |
SRRA | SIERRA ONCOLOGY INC | 9 | 9 | 0.01% | 0.05% | 0.15% | Q1 2017 | Q1 2019 | 9 |
OREXIGEN THERAPEUTICS INC | 9 | 9 | 0.02% | 0.03% | 0.07% | Q4 2014 | Q4 2016 | 9 | |
THESEUS PHARMACEUTICAL... | 8 | 8 | 1.01% | 2.26% | 3.19% | Q4 2021 | Q3 2023 | 8 | |
CMPX | COMPASS THERAPEUTICS INC | 8 | 8 | 0.48% | 1.14% | 2.15% | Q4 2021 | Q3 2023 | 8 |
BAX | BAXTER INTL INC | 3 | 1 | 0.11% | 0.85% | 2.79% | Q2 2013 | Q3 2023 | 8 |
ARVN | ARVINAS INC | 8 | 8 | 0.01% | 0.67% | 1.11% | Q3 2018 | Q2 2020 | 8 |
APLS | APELLIS PHARMACEUTICAL... | 4 | 1 | 0.02% | 0.67% | 1.50% | Q4 2018 | Q3 2023 | 8 |
RYTM | RHYTHM PHARMACEUTICALS... | 7 | 1 | 0.27% | 0.47% | 0.77% | Q4 2017 | Q3 2023 | 8 |
RAPT | RAPT THERAPEUTICS INC | 8 | 8 | 0.10% | 0.36% | 0.56% | Q4 2021 | Q3 2023 | 8 |
DMTX | DIMENSION THERAPEUTICS... | 8 | 8 | 0.08% | 0.33% | 0.55% | Q4 2015 | Q3 2017 | 8 |
VENTYX BIOSCIENCES INC | 8 | 8 | 0.15% | 0.32% | 0.58% | Q4 2021 | Q3 2023 | 8 | |
KZR | KEZAR LIFE SCIENCES INC | 6 | 2 | 0.03% | 0.25% | 0.62% | Q2 2021 | Q3 2023 | 8 |
FOMX | FOAMIX PHARMACEUTICALS... | 8 | 8 | 0.07% | 0.24% | 0.36% | Q1 2018 | Q4 2019 | 8 |
RARE | ULTRAGENYX PHARMACEUTI... | 4 | 1 | 0.06% | 0.19% | 0.68% | Q1 2016 | Q1 2022 | 8 |
STDY | STEADYMED LTD | 8 | 8 | 0.10% | 0.18% | 0.28% | Q3 2016 | Q2 2018 | 8 |
APTOSE BIOSCIENCES INC | 8 | 8 | 0.06% | 0.18% | 0.45% | Q4 2019 | Q3 2021 | 8 | |
MRGE | MERGE HEALTHCARE INC | 8 | 8 | 0.11% | 0.15% | 0.20% | Q3 2013 | Q2 2015 | 8 |
ALXN | ALEXION PHARMACEUTICAL... | 2 | 1 | 0.07% | 0.14% | 0.21% | Q3 2013 | Q1 2021 | 8 |
WMGIZ | WRIGHT MED GROUP N V | 8 | 8 | 0.00% | 0.12% | 0.17% | Q1 2017 | Q4 2018 | 8 |
LUNG | PULMONX CORP | 8 | 8 | 0.05% | 0.12% | 0.18% | Q4 2020 | Q3 2022 | 8 |
SUPN | SUPERNUS PHARMACEUTICA... | 8 | 8 | 0.05% | 0.10% | 0.34% | Q2 2013 | Q1 2015 | 8 |
CRIS | CURIS INC | 8 | 8 | 0.02% | 0.07% | 0.16% | Q2 2013 | Q1 2015 | 8 |
UPI | UROPLASTY INC | 8 | 8 | 0.01% | 0.05% | 0.08% | Q2 2013 | Q1 2015 | 8 |
MCRB | SERES THERAPEUTICS INC | 5 | 3 | 0.01% | 0.04% | 0.08% | Q2 2015 | Q1 2018 | 8 |
IFRX | INFLARX NV | 8 | 8 | 0.02% | 0.04% | 0.07% | Q1 2020 | Q4 2021 | 8 |
PRVL | PREVAIL THERAPEUTICS INC | 7 | 7 | 1.77% | 2.78% | 3.22% | Q2 2019 | Q4 2020 | 7 |
CMTA | CLEMENTIA PHARMACEUTIC... | 7 | 7 | 1.40% | 2.24% | 4.21% | Q3 2017 | Q1 2019 | 7 |
AGN | ALLERGAN INC | 7 | 7 | 0.48% | 1.71% | 3.46% | Q2 2013 | Q4 2014 | 7 |
SGEN | SEAGEN INC | 6 | 1 | 0.19% | 1.42% | 2.25% | Q3 2021 | Q3 2023 | 7 |
BHC | BAUSCH HEALTH COS INC | 7 | 7 | 0.59% | 1.15% | 1.46% | Q3 2018 | Q1 2020 | 7 |
IONS | IONIS PHARMACEUTICALS INC | 6 | 1 | 0.09% | 1.09% | 2.09% | Q4 2019 | Q3 2023 | 7 |
ALNY | ALNYLAM PHARMACEUTICAL... | 6 | 1 | 0.05% | 1.09% | 1.87% | Q1 2017 | Q3 2022 | 7 |
WCG | WELLCARE HEALTH PLANS INC | 5 | 2 | 0.10% | 1.05% | 2.15% | Q2 2013 | Q3 2016 | 7 |
NVRO | NEVRO CORP | 7 | 7 | 0.08% | 0.73% | 1.35% | Q1 2017 | Q3 2018 | 7 |
TNDM | TANDEM DIABETES CARE INC | 7 | 7 | 0.37% | 0.63% | 0.97% | Q2 2018 | Q4 2019 | 7 |
STJ | ST JUDE MED INC | 7 | 7 | 0.11% | 0.58% | 1.35% | Q2 2013 | Q4 2014 | 7 |
XLRN | ACCELERON PHARMA INC | 4 | 3 | 0.07% | 0.51% | 1.23% | Q4 2013 | Q3 2020 | 7 |
ACRS | ACLARIS THERAPEUTICS INC | 7 | 7 | 0.06% | 0.43% | 0.83% | Q2 2021 | Q4 2022 | 7 |
RDUS | RADIUS HEALTH INC | 7 | 7 | 0.16% | 0.34% | 0.55% | Q1 2017 | Q3 2018 | 7 |
GMTX | GEMINI THERAPEUTICS INC | 7 | 7 | 0.13% | 0.30% | 0.74% | Q1 2021 | Q3 2022 | 7 |
ALC | ALCON INC | 7 | 7 | 0.20% | 0.29% | 0.39% | Q2 2019 | Q4 2020 | 7 |
MDT | MEDTRONIC INC | 7 | 7 | 0.21% | 0.29% | 0.39% | Q2 2013 | Q4 2014 | 7 |
RXSIGHT INC | 7 | 7 | 0.17% | 0.28% | 0.39% | Q3 2021 | Q1 2023 | 7 | |
VTGN | VISTAGEN THERAPEUTICS INC | 7 | 7 | 0.13% | 0.28% | 0.46% | Q4 2020 | Q2 2022 | 7 |
JNCE | JOUNCE THERAPEUTICS INC | 7 | 7 | 0.13% | 0.21% | 0.32% | Q1 2021 | Q3 2022 | 7 |
XOMA | XOMA CORP DEL | 7 | 7 | 0.07% | 0.17% | 0.28% | Q2 2013 | Q4 2014 | 7 |
NBRV | NABRIVA THERAPEUTICS AG | 7 | 7 | 0.10% | 0.13% | 0.23% | Q3 2015 | Q1 2017 | 7 |
VOR | VOR BIOPHARMA INC | 7 | 7 | 0.01% | 0.13% | 0.34% | Q1 2021 | Q3 2022 | 7 |
IMAB | I MAB | 7 | 7 | 0.01% | 0.13% | 0.36% | Q3 2020 | Q1 2022 | 7 |
VNDA | VANDA PHARMACEUTICALS INC | 4 | 3 | 0.01% | 0.13% | 0.19% | Q4 2013 | Q4 2017 | 7 |
ACHL | ACHILLES THERAPEUTICS PLC | 7 | 7 | 0.06% | 0.12% | 0.24% | Q1 2021 | Q3 2022 | 7 |
SAGE | SAGE THERAPEUTICS INC | 5 | 1 | 0.06% | 0.12% | 0.18% | Q3 2014 | Q4 2018 | 7 |
MGTA | MAGENTA THERAPEUTICS INC | 7 | 7 | 0.05% | 0.11% | 0.20% | Q1 2021 | Q3 2022 | 7 |
NSPR | INSPIREMD INC | 7 | 7 | 0.02% | 0.11% | 0.16% | Q2 2013 | Q4 2014 | 7 |
MGNX | MACROGENICS INC | 5 | 2 | 0.04% | 0.10% | 0.20% | Q4 2013 | Q2 2016 | 7 |
OCX | ONCOCYTE CORP | 7 | 7 | 0.03% | 0.08% | 0.12% | Q1 2021 | Q3 2022 | 7 |
HCAT | HEALTH CATALYST INC | 7 | 7 | 0.07% | 0.08% | 0.11% | Q3 2019 | Q1 2021 | 7 |
VIGIL NEUROSCIENCE INC | 7 | 7 | 0.02% | 0.06% | 0.11% | Q1 2022 | Q3 2023 | 7 | |
BIOD | BIODEL INC | 7 | 7 | 0.00% | 0.05% | 0.24% | Q2 2013 | Q4 2014 | 7 |
LBPH | LONGBOARD PHARMACEUTIC... | 7 | 7 | 0.01% | 0.01% | 0.05% | Q1 2021 | Q3 2022 | 7 |
B108PS | ACTAVIS PLC | 6 | 6 | 1.25% | 2.62% | 4.01% | Q4 2013 | Q1 2015 | 6 |
MYL | MYLAN INC | 6 | 6 | 0.08% | 2.37% | 3.44% | Q2 2013 | Q3 2014 | 6 |
CFN | CAREFUSION CORP | 6 | 6 | 0.12% | 1.22% | 2.25% | Q2 2013 | Q3 2014 | 6 |
TRNX | TORNIER N V | 6 | 6 | 0.38% | 0.97% | 1.20% | Q1 2014 | Q2 2015 | 6 |
AGNPRA | ALLERGAN PLC | 4 | 1 | 0.80% | 0.91% | 1.01% | Q2 2015 | Q1 2017 | 6 |
CYH | COMMUNITY HEALTH SYS I... | 4 | 2 | 0.20% | 0.59% | 1.17% | Q2 2013 | Q1 2016 | 6 |
OSH | OAK STR HEALTH INC | 6 | 6 | 0.22% | 0.49% | 0.79% | Q3 2020 | Q4 2021 | 6 |
TVTX | TRAVERE THERAPEUTICS INC | 5 | 1 | 0.12% | 0.48% | 0.77% | Q1 2021 | Q2 2023 | 6 |
CLDX | CELLDEX THERAPEUTICS I... | 6 | 6 | 0.14% | 0.37% | 0.51% | Q4 2013 | Q1 2015 | 6 |
MREO | MEREO BIOPHARMA GROUP PLC | 3 | 3 | 0.13% | 0.36% | 0.55% | Q4 2020 | Q2 2022 | 6 |
IMMUNOMEDICS INC | 6 | 6 | 0.21% | 0.36% | 0.57% | Q1 2016 | Q2 2017 | 6 | |
DRTX | DURATA THERAPEUTICS INC | 6 | 6 | 0.24% | 0.30% | 0.36% | Q2 2013 | Q3 2014 | 6 |
TRILLIUM THERAPEUTICS INC | 6 | 6 | 0.05% | 0.24% | 0.38% | Q1 2020 | Q2 2021 | 6 | |
AMBI | AMBIT BIOSCIENCES CORP | 6 | 6 | 0.12% | 0.23% | 0.41% | Q2 2013 | Q3 2014 | 6 |
BRIDGEBIO PHARMA INC | 6 | 6 | 0.17% | 0.22% | 0.25% | Q1 2022 | Q2 2023 | 6 | |
MREO | MEREO BIOPHARMA GROUP PLC | 5 | 1 | 0.05% | 0.19% | 0.46% | Q3 2021 | Q1 2023 | 6 |
GRPH | GRAPHITE BIO INC | 6 | 6 | 0.04% | 0.18% | 0.34% | Q2 2021 | Q3 2022 | 6 |
CYNA | CYNAPSUS THERAPEUTICS INC | 6 | 6 | 0.14% | 0.18% | 0.23% | Q2 2015 | Q3 2016 | 6 |
ABBV | ABBVIE INC | 3 | 1 | 0.14% | 0.18% | 0.22% | Q3 2013 | Q2 2020 | 6 |
CLDX | CELLDEX THERAPEUTICS I... | 4 | 2 | 0.06% | 0.16% | 0.25% | Q2 2020 | Q2 2022 | 6 |
CLXPF | CYBIN INC | 6 | 6 | 0.03% | 0.14% | 0.32% | Q3 2021 | Q4 2022 | 6 |
SRRK | SCHOLAR ROCK HLDG CORP | 6 | 6 | 0.08% | 0.14% | 0.31% | Q2 2022 | Q3 2023 | 6 |
BCR | BARD C R INC | 4 | 2 | 0.06% | 0.12% | 0.17% | Q2 2013 | Q1 2017 | 6 |
GEVA | SYNAGEVA BIOPHARMA CORP | 6 | 6 | 0.07% | 0.11% | 0.15% | Q3 2013 | Q4 2014 | 6 |
NRIX | NURIX THERAPEUTICS INC | 6 | 6 | 0.07% | 0.11% | 0.19% | Q3 2020 | Q4 2021 | 6 |
ITEK | INOTEK PHARMACEUTICALS... | 6 | 6 | 0.04% | 0.11% | 0.20% | Q3 2015 | Q4 2016 | 6 |
AMED | AMEDISYS INC | 3 | 3 | 0.01% | 0.09% | 0.17% | Q2 2016 | Q2 2018 | 6 |
CNXR | CONNECTURE INC | 6 | 6 | 0.03% | 0.08% | 0.15% | Q4 2014 | Q1 2016 | 6 |
SRPT | SAREPTA THERAPEUTICS INC | 3 | 1 | 0.04% | 0.08% | 0.20% | Q3 2017 | Q1 2023 | 6 |
ARNA | ARENA PHARMACEUTICALS INC | 6 | 6 | 0.06% | 0.08% | 0.10% | Q2 2019 | Q3 2020 | 6 |
KALV | KALVISTA PHARMACEUTICA... | 3 | 1 | 0.01% | 0.08% | 0.28% | Q1 2019 | Q3 2022 | 6 |
MDXG | MIMEDX GROUP INC | 6 | 6 | 0.06% | 0.07% | 0.09% | Q4 2013 | Q1 2015 | 6 |
ADXS | ADVAXIS INC | 6 | 6 | 0.04% | 0.06% | 0.11% | Q1 2015 | Q2 2016 | 6 |
HSAQ | HEALTH SCIENCES ACQ CO... | 6 | 6 | 0.05% | 0.06% | 0.07% | Q3 2020 | Q4 2021 | 6 |
MNLO | MENLO THERAPEUTICS INC | 3 | 1 | 0.01% | 0.06% | 0.08% | Q3 2018 | Q2 2020 | 6 |
IRWD | IRONWOOD PHARMACEUTICA... | 4 | 2 | 0.03% | 0.05% | 0.08% | Q1 2014 | Q3 2018 | 6 |
APTX | APTINYX INC | 4 | 2 | 0.00% | 0.02% | 0.04% | Q4 2019 | Q2 2022 | 6 |
CGNT | COGENTIX MED INC | 6 | 6 | 0.01% | 0.01% | 0.02% | Q2 2015 | Q3 2016 | 6 |
MDGS | MEDIGUS LTD | 6 | 6 | 0.00% | 0.01% | 0.03% | Q3 2015 | Q4 2016 | 6 |
NVLNF | NOVELION THERAPEUTICS INC | 6 | 6 | 0.00% | 0.01% | 0.01% | Q4 2016 | Q1 2018 | 6 |
MDGS | MEDIGUS LTD | 6 | 6 | 0.00% | 0.00% | 0.00% | Q1 2017 | Q2 2018 | 6 |
MDGS | MEDIGUS LTD | 6 | 6 | 0.00% | 0.00% | 0.00% | Q3 2018 | Q4 2019 | 6 |
THOR | SYNTHORX INC | 5 | 5 | 1.11% | 2.29% | 5.30% | Q4 2018 | Q4 2019 | 5 |
PRGO | PERRIGO CO PLC | 5 | 5 | 1.76% | 1.92% | 2.02% | Q1 2014 | Q1 2015 | 5 |
ITMN | INTERMUNE INC | 5 | 5 | 0.05% | 1.55% | 2.81% | Q2 2013 | Q2 2014 | 5 |
PRNB | PRINCIPIA BIOPHARMA INC | 5 | 5 | 0.82% | 1.06% | 1.37% | Q3 2018 | Q3 2019 | 5 |
V107SC | WELLPOINT INC | 3 | 2 | 0.08% | 0.93% | 2.06% | Q2 2013 | Q3 2014 | 5 |
T107PS | WRIGHT MED GROUP INC | 5 | 5 | 0.56% | 0.86% | 1.68% | Q3 2014 | Q3 2015 | 5 |
THIRD HARMONIC BIO INC | 5 | 5 | 0.47% | 0.85% | 2.04% | Q3 2022 | Q3 2023 | 5 | |
AGNPRA | ALLERGAN PLC | 3 | 1 | 0.53% | 0.74% | 0.91% | Q2 2016 | Q4 2017 | 5 |
ATRC | ATRICURE INC | 5 | 5 | 0.08% | 0.52% | 0.78% | Q4 2019 | Q4 2020 | 5 |
MYOK | MYOKARDIA INC | 5 | 5 | 0.03% | 0.52% | 0.78% | Q4 2018 | Q4 2019 | 5 |
NXTM | NXSTAGE MEDICAL INC | 5 | 5 | 0.13% | 0.51% | 0.98% | Q2 2013 | Q2 2014 | 5 |
DVAX | DYNAVAX TECHNOLOGIES CORP | 4 | 1 | 0.04% | 0.39% | 0.61% | Q3 2015 | Q2 2019 | 5 |
RCPT | RECEPTOS INC | 3 | 2 | 0.18% | 0.37% | 0.88% | Q2 2013 | Q2 2015 | 5 |
MNTA | MOMENTA PHARMACEUTICAL... | 5 | 5 | 0.20% | 0.37% | 0.57% | Q4 2016 | Q4 2017 | 5 |
ARCT | ARCTURUS THERAPEUTICS ... | 5 | 5 | 0.16% | 0.35% | 0.49% | Q2 2020 | Q2 2021 | 5 |
CBST | CUBIST PHARMACEUTICALS... | 5 | 5 | 0.07% | 0.27% | 1.02% | Q2 2013 | Q2 2014 | 5 |
ONCE | SPARK THERAPEUTICS INC | 2 | 1 | 0.07% | 0.26% | 0.45% | Q1 2015 | Q3 2019 | 5 |
ASNS | ARSANIS INC | 5 | 5 | 0.04% | 0.21% | 0.53% | Q4 2017 | Q4 2018 | 5 |
BRIDGEBIO PHARMA INC | 5 | 5 | 0.15% | 0.18% | 0.22% | Q1 2022 | Q1 2023 | 5 | |
MEIP | MEI PHARMA INC | 5 | 5 | 0.10% | 0.18% | 0.26% | Q4 2013 | Q4 2014 | 5 |
ISEE | IVERIC BIO INC | 4 | 1 | 0.04% | 0.18% | 0.24% | Q4 2019 | Q2 2022 | 5 |
RCKT | ROCKET PHARMACEUTICALS... | 3 | 2 | 0.07% | 0.16% | 0.23% | Q1 2018 | Q3 2020 | 5 |
HZNP | HORIZON PHARMA PLC | 5 | 5 | 0.04% | 0.15% | 0.24% | Q3 2014 | Q3 2015 | 5 |
RLAY | RELAY THERAPEUTICS INC | 4 | 1 | 0.09% | 0.13% | 0.19% | Q3 2020 | Q3 2023 | 5 |
ARWR | ARROWHEAD PHARMACEUTIC... | 2 | 1 | 0.03% | 0.12% | 0.25% | Q3 2016 | Q3 2023 | 5 |
CNST | CONSTELLATION PHARMCET... | 5 | 5 | 0.06% | 0.11% | 0.18% | Q3 2018 | Q3 2019 | 5 |
VCRA | VOCERA COMMUNICATIONS INC | 5 | 5 | 0.07% | 0.11% | 0.15% | Q2 2013 | Q2 2014 | 5 |
SYRS | SYROS PHARMACEUTICALS INC | 5 | 5 | 0.08% | 0.11% | 0.15% | Q4 2020 | Q4 2021 | 5 |
CTMX | CYTOMX THERAPEUTICS INC | 5 | 5 | 0.07% | 0.11% | 0.18% | Q2 2021 | Q2 2022 | 5 |
FRX | FOREST LABS INC | 5 | 5 | 0.09% | 0.11% | 0.12% | Q2 2013 | Q2 2014 | 5 |
BONE | BACTERIN INTL HLDGS INC | 5 | 5 | 0.02% | 0.10% | 0.38% | Q2 2013 | Q2 2014 | 5 |
NANOSTRING TECHNOLOGIE... | 5 | 5 | 0.09% | 0.09% | 0.10% | Q2 2021 | Q2 2022 | 5 | |
QCOR | QUESTCOR PHARMACEUTICA... | 5 | 5 | 0.06% | 0.08% | 0.14% | Q2 2013 | Q2 2014 | 5 |
DYN | DYNE THERAPEUTICS INC | 4 | 1 | 0.05% | 0.07% | 0.09% | Q3 2020 | Q3 2022 | 5 |
INZY | INOZYME PHARMA INC | 3 | 2 | 0.03% | 0.06% | 0.13% | Q3 2020 | Q4 2021 | 5 |
CPRX | CATALYST PHARM PARTNER... | 4 | 1 | 0.05% | 0.06% | 0.10% | Q3 2013 | Q3 2018 | 5 |
NERV | MINERVA NEUROSCIENCES INC | 5 | 5 | 0.03% | 0.06% | 0.09% | Q2 2016 | Q2 2017 | 5 |
SBBP | STRONGBRIDGE BIOPHARMA... | 5 | 5 | 0.02% | 0.06% | 0.09% | Q3 2020 | Q3 2021 | 5 |
ASLN | ASLAN PHARMACEUTICALS LTD | 5 | 5 | 0.03% | 0.05% | 0.08% | Q1 2021 | Q1 2022 | 5 |
STRO | SUTRO BIOPHARMA INC | 3 | 2 | 0.02% | 0.05% | 0.08% | Q4 2019 | Q2 2021 | 5 |
LABP | LANDOS BIOPHARMA INC | 5 | 5 | 0.01% | 0.04% | 0.08% | Q1 2021 | Q1 2022 | 5 |
TALS | TALARIS THERAPEUTICS INC | 5 | 5 | 0.02% | 0.04% | 0.05% | Q2 2021 | Q2 2022 | 5 |
DSCI | DERMA SCIENCES INC | 5 | 5 | 0.02% | 0.03% | 0.05% | Q1 2014 | Q1 2015 | 5 |
BOLT | BOLT BIOTHERAPEUTICS INC | 5 | 5 | 0.02% | 0.03% | 0.04% | Q3 2022 | Q3 2023 | 5 |
NLNK | NEWLINK GENETICS CORP | 3 | 1 | 0.01% | 0.03% | 0.06% | Q2 2014 | Q3 2017 | 5 |
BMYRT | BRISTOL-MYERS SQUIBB CO | 5 | 5 | 0.00% | 0.01% | 0.02% | Q4 2019 | Q4 2020 | 5 |
ENDOLOGIX INC | 5 | 5 | 0.01% | 0.01% | 0.02% | Q4 2013 | Q4 2014 | 5 | |
BLRX | BIOLINERX LTD | 5 | 5 | 0.00% | 0.00% | 0.00% | Q3 2019 | Q3 2020 | 5 |
BONE | BACTERIN INTL HLDGS INC | 4 | 4 | 0.01% | 3.07% | 12.21% | Q3 2014 | Q2 2015 | 4 |
DISC MEDICINE INC | 4 | 4 | 0.82% | 1.46% | 2.26% | Q4 2022 | Q3 2023 | 4 | |
AGIO | AGIOS PHARMACEUTICALS INC | 4 | 4 | 0.84% | 1.02% | 1.30% | Q1 2020 | Q4 2020 | 4 |
ARWR | ARROWHEAD RESH CORP | 4 | 4 | 0.34% | 0.69% | 0.83% | Q4 2013 | Q3 2014 | 4 |
UHS | UNIVERSAL HLTH SVCS INC | 4 | 4 | 0.25% | 0.68% | 1.14% | Q3 2017 | Q2 2018 | 4 |
EGRX | EAGLE PHARMACEUTICALS INC | 4 | 4 | 0.42% | 0.64% | 0.83% | Q2 2016 | Q1 2017 | 4 |
ACHC | ACADIA HEALTHCARE COMP... | 4 | 4 | 0.41% | 0.45% | 0.49% | Q1 2020 | Q4 2020 | 4 |
KRYS | KRYSTAL BIOTECH INC | 4 | 4 | 0.03% | 0.40% | 0.79% | Q1 2019 | Q4 2019 | 4 |
ATRS | ANTARES PHARMA INC | 4 | 4 | 0.14% | 0.39% | 0.81% | Q2 2013 | Q1 2014 | 4 |
IQV | IQVIA HLDGS INC | 4 | 4 | 0.32% | 0.39% | 0.50% | Q3 2019 | Q2 2020 | 4 |
2SEVENTY BIO INC | 4 | 4 | 0.19% | 0.35% | 0.48% | Q3 2022 | Q2 2023 | 4 | |
EVHC | ENVISION HEALTHCARE CORP | 4 | 4 | 0.19% | 0.34% | 0.42% | Q2 2017 | Q1 2018 | 4 |
QGEN | QIAGEN NV | 2 | 1 | 0.06% | 0.34% | 0.67% | Q4 2013 | Q1 2016 | 4 |
ERASCA INC | 4 | 4 | 0.17% | 0.31% | 0.50% | Q3 2021 | Q2 2022 | 4 | |
INSMED INC | 4 | 4 | 0.22% | 0.27% | 0.29% | Q1 2018 | Q4 2018 | 4 | |
ZYME | ZYMEWORKS INC | 4 | 4 | 0.13% | 0.24% | 0.35% | Q1 2020 | Q4 2020 | 4 |
OLMA | OLEMA PHARMACEUTICALS INC | 4 | 4 | 0.20% | 0.24% | 0.27% | Q4 2020 | Q3 2021 | 4 |
AGN | ALLERGAN PLC | 3 | 1 | 0.06% | 0.21% | 0.36% | Q2 2015 | Q3 2016 | 4 |
PCRX | PACIRA PHARMACEUTICALS... | 3 | 1 | 0.13% | 0.21% | 0.31% | Q2 2013 | Q1 2015 | 4 |
GDRX | GOODRX HLDGS INC | 4 | 4 | 0.04% | 0.15% | 0.21% | Q4 2022 | Q3 2023 | 4 |
LRMR | LARIMAR THERAPEUTICS INC | 4 | 4 | 0.08% | 0.15% | 0.17% | Q2 2020 | Q1 2021 | 4 |
LLY | LILLY ELI & CO | 2 | 1 | 0.09% | 0.14% | 0.23% | Q2 2013 | Q3 2022 | 4 |
AGEN | AGENUS INC | 4 | 4 | 0.09% | 0.14% | 0.20% | Q1 2014 | Q4 2014 | 4 |
VOLCANO CORPORATION | 4 | 4 | 0.03% | 0.12% | 0.18% | Q1 2014 | Q4 2014 | 4 | |
FBRX | FORTE BIOSCIENCES INC | 4 | 4 | 0.03% | 0.12% | 0.21% | Q2 2020 | Q1 2021 | 4 |
ENSG | ENSIGN GROUP INC | 4 | 4 | 0.09% | 0.11% | 0.12% | Q2 2015 | Q1 2016 | 4 |
ZTS | ZOETIS INC | 3 | 1 | 0.08% | 0.10% | 0.13% | Q2 2013 | Q2 2014 | 4 |
BCAB | BIOATLA INC | 4 | 4 | 0.04% | 0.09% | 0.20% | Q4 2022 | Q3 2023 | 4 |
PBYI | PUMA BIOTECHNOLOGY INC | 2 | 1 | 0.03% | 0.09% | 0.15% | Q2 2014 | Q3 2019 | 4 |
MIRM | MIRUM PHARMACEUTICALS INC | 3 | 1 | 0.01% | 0.08% | 0.20% | Q4 2019 | Q3 2022 | 4 |
CBIO | CATALYST BIOSCIENCES INC | 4 | 4 | 0.02% | 0.08% | 0.12% | Q1 2021 | Q4 2021 | 4 |
ANAB | ANAPTYSBIO INC | 4 | 4 | 0.03% | 0.08% | 0.12% | Q4 2019 | Q3 2020 | 4 |
CVD | COVANCE INC | 4 | 4 | 0.07% | 0.08% | 0.08% | Q2 2013 | Q1 2014 | 4 |
RXDX | PROMETHEUS BIOSCIENCES... | 4 | 4 | 0.04% | 0.07% | 0.13% | Q1 2021 | Q4 2021 | 4 |
NVTRQ | NUVECTRA CORP | 4 | 4 | 0.02% | 0.07% | 0.11% | Q3 2018 | Q2 2019 | 4 |
NBTX | NANOBIOTIX SA | 4 | 4 | 0.06% | 0.07% | 0.07% | Q4 2020 | Q3 2021 | 4 |
SPRO | SPERO THERAPEUTICS INC | 4 | 4 | 0.02% | 0.06% | 0.10% | Q1 2019 | Q4 2019 | 4 |
ANAC | ANACOR PHARMACEUTICALS... | 4 | 4 | 0.03% | 0.06% | 0.07% | Q2 2015 | Q1 2016 | 4 |
IPXL | IMPAX LABORATORIES INC | 4 | 4 | 0.04% | 0.05% | 0.06% | Q3 2014 | Q2 2015 | 4 |
BITI | BIOTIE THERAPIES OYJ | 4 | 4 | 0.04% | 0.05% | 0.08% | Q2 2015 | Q1 2016 | 4 |
ANTH | ANTHERA PHARMACEUTICAL... | 4 | 4 | 0.04% | 0.05% | 0.07% | Q3 2013 | Q2 2014 | 4 |
RLM | REALM THERAPEUTICS PLC | 4 | 4 | 0.04% | 0.04% | 0.06% | Q3 2018 | Q2 2019 | 4 |
SIGHT SCIENCES INC | 4 | 4 | 0.03% | 0.04% | 0.05% | Q3 2021 | Q2 2022 | 4 | |
ADAG | ADAGENE INC | 4 | 4 | 0.03% | 0.04% | 0.05% | Q1 2021 | Q4 2021 | 4 |
ROKA | ROKA BIOSCIENCE INC | 4 | 4 | 0.00% | 0.03% | 0.05% | Q4 2016 | Q3 2017 | 4 |
OREXIGEN THERAPEUTICS INC | 4 | 4 | 0.02% | 0.02% | 0.03% | Q1 2017 | Q4 2017 | 4 | |
PYXIS ONCOLOGY INC | 2 | 2 | 0.01% | 0.02% | 0.03% | Q4 2021 | Q4 2022 | 4 | |
MNKD | MANNKIND CORP | 3 | 1 | 0.01% | 0.02% | 0.02% | Q1 2014 | Q4 2015 | 4 |
REPH | RECRO PHARMA INC | 4 | 4 | 0.00% | 0.01% | 0.01% | Q2 2018 | Q1 2019 | 4 |
ENLIVEN THERAPEUTICS INC | 3 | 3 | 2.61% | 3.27% | 3.87% | Q1 2023 | Q3 2023 | 3 | |
AVDR | AVEDRO INC | 3 | 3 | 0.80% | 1.31% | 1.83% | Q1 2019 | Q3 2019 | 3 |
BHVN | BIOHAVEN PHARMACTL HLD... | 3 | 3 | 0.48% | 1.25% | 1.90% | Q1 2022 | Q3 2022 | 3 |
UTHR | UNITED THERAPEUTICS CO... | 2 | 1 | 0.09% | 1.21% | 1.93% | Q4 2013 | Q3 2023 | 3 |
SHPG | SHIRE PLC | 2 | 1 | 0.10% | 1.05% | 2.57% | Q3 2014 | Q4 2018 | 3 |
R1 RCM INC | 3 | 3 | 0.52% | 0.92% | 1.15% | Q1 2023 | Q3 2023 | 3 | |
PFE | PFIZER INC | 1 | 1 | 0.27% | 0.85% | 1.92% | Q2 2013 | Q3 2020 | 3 |
XRAY | DENTSPLY SIRONA INC | 3 | 3 | 0.14% | 0.75% | 1.25% | Q1 2018 | Q3 2018 | 3 |
JUNO | JUNO THERAPEUTICS INC | 3 | 3 | 0.29% | 0.74% | 1.06% | Q2 2017 | Q4 2017 | 3 |
P103PS | NPS PHARMACEUTICALS INC | 3 | 3 | 0.21% | 0.64% | 1.01% | Q2 2014 | Q4 2014 | 3 |
APOLLOMICS INC | 3 | 3 | 0.07% | 0.60% | 1.43% | Q1 2023 | Q3 2023 | 3 | |
MD | MEDNAX INC | 3 | 3 | 0.26% | 0.51% | 0.83% | Q1 2018 | Q3 2018 | 3 |
TFX | TELEFLEX INC | 3 | 3 | 0.37% | 0.49% | 0.61% | Q1 2018 | Q3 2018 | 3 |
AGN | ALLERGAN INC | 2 | 1 | 0.30% | 0.44% | 0.51% | Q1 2014 | Q4 2014 | 3 |
ENDP | ENDO INTL PLC | 2 | 1 | 0.10% | 0.42% | 0.77% | Q4 2017 | Q2 2019 | 3 |
IART | INTEGRA LIFESCIENCES H... | 3 | 3 | 0.24% | 0.40% | 0.53% | Q2 2017 | Q4 2017 | 3 |
VERA | VERA THERAPEUTICS INC | 3 | 3 | 0.21% | 0.39% | 0.51% | Q1 2023 | Q3 2023 | 3 |
IBB | ISHARES TR | 2 | 1 | 0.29% | 0.37% | 0.45% | Q1 2014 | Q3 2019 | 3 |
DNAI | PRONAI THERAPEUTICS INC | 3 | 3 | 0.12% | 0.27% | 0.41% | Q3 2015 | Q1 2016 | 3 |
NVAX | NOVAVAX INC | 3 | 3 | 0.10% | 0.27% | 0.43% | Q1 2021 | Q3 2021 | 3 |
PAND | PANDION THERAPEUTICS INC | 3 | 3 | 0.19% | 0.23% | 0.30% | Q3 2020 | Q1 2021 | 3 |
TAK | TAKEDA PHARMACEUTICAL ... | 3 | 3 | 0.21% | 0.23% | 0.24% | Q1 2019 | Q3 2019 | 3 |
KPTI | KARYOPHARM THERAPEUTIC... | 3 | 3 | 0.17% | 0.22% | 0.29% | Q2 2019 | Q4 2019 | 3 |
DHRPRB | DANAHER CORPORATION | 3 | 3 | 0.19% | 0.21% | 0.22% | Q4 2021 | Q2 2022 | 3 |
IMTX | IMMATICS N.V | 3 | 3 | 0.13% | 0.20% | 0.26% | Q1 2023 | Q3 2023 | 3 |
FPRX | FIVE PRIME THERAPEUTIC... | 3 | 3 | 0.13% | 0.20% | 0.26% | Q1 2014 | Q3 2014 | 3 |
TECH | TECHNE CORP | 3 | 3 | 0.07% | 0.19% | 0.38% | Q2 2013 | Q4 2013 | 3 |
ENTA | ENANTA PHARMACEUTICALS... | 2 | 1 | 0.08% | 0.19% | 0.34% | Q4 2015 | Q1 2019 | 3 |
F113PS | COVIDIEN PLC | 3 | 3 | 0.16% | 0.19% | 0.21% | Q2 2014 | Q4 2014 | 3 |
VSTM | VERASTEM INC | 3 | 3 | 0.13% | 0.18% | 0.27% | Q3 2022 | Q1 2023 | 3 |
AZN | ASTRAZENECA PLC | 1 | 1 | 0.00% | 0.17% | 0.36% | Q1 2014 | Q3 2023 | 3 |
SGFY | SIGNIFY HEALTH INC | 2 | 1 | 0.06% | 0.16% | 0.22% | Q1 2021 | Q2 2022 | 3 |
ADRO | ADURO BIOTECH INC | 3 | 3 | 0.02% | 0.15% | 0.24% | Q2 2015 | Q4 2015 | 3 |
SGEN | SEAGEN INC | 2 | 1 | 0.06% | 0.15% | 0.22% | Q2 2022 | Q3 2023 | 3 |
MYL | MYLAN INC | 2 | 1 | 0.06% | 0.13% | 0.20% | Q2 2013 | Q2 2014 | 3 |
AMAG | AMAG PHARMACEUTICALS INC | 3 | 3 | 0.05% | 0.12% | 0.19% | Q3 2014 | Q1 2015 | 3 |
CVRX | CVRX INC | 3 | 3 | 0.11% | 0.12% | 0.14% | Q2 2021 | Q4 2021 | 3 |
NAUT | NAUTILUS BIOTECHNOLOGY... | 3 | 3 | 0.10% | 0.12% | 0.16% | Q2 2021 | Q4 2021 | 3 |
SLXP | SALIX PHARMACEUTICALS INC | 3 | 3 | 0.09% | 0.12% | 0.13% | Q3 2014 | Q1 2015 | 3 |
CMPS | COMPASS PATHWAYS PLC | 3 | 3 | 0.04% | 0.11% | 0.15% | Q3 2020 | Q1 2021 | 3 |
PSNL | PERSONALIS INC | 3 | 3 | 0.08% | 0.11% | 0.14% | Q2 2019 | Q4 2019 | 3 |
BXLT | BAXALTA INC | 3 | 3 | 0.09% | 0.11% | 0.14% | Q3 2015 | Q1 2016 | 3 |
YS BIOPHARMA CO LTD | 3 | 3 | 0.08% | 0.11% | 0.14% | Q1 2023 | Q3 2023 | 3 | |
IPSC | CENTURY THERAPEUTICS INC | 3 | 3 | 0.06% | 0.10% | 0.12% | Q2 2021 | Q4 2021 | 3 |
SONENDO INC | 3 | 3 | 0.02% | 0.10% | 0.15% | Q4 2021 | Q2 2022 | 3 | |
WMGI | WRIGHT MED GROUP N V | 1 | 1 | 0.07% | 0.09% | 0.12% | Q2 2016 | Q1 2019 | 3 |
SNSS | SUNESIS PHARMACEUTICAL... | 3 | 3 | 0.09% | 0.09% | 0.10% | Q1 2014 | Q3 2014 | 3 |
FLDM | FLUIDIGM CORP DEL | 2 | 1 | 0.02% | 0.08% | 0.14% | Q1 2014 | Q1 2021 | 3 |
AKUS | AKOUOS INC | 3 | 3 | 0.06% | 0.08% | 0.10% | Q2 2020 | Q4 2020 | 3 |
TEVA | TEVA PHARMACEUTICAL IN... | 2 | 1 | 0.00% | 0.08% | 0.20% | Q3 2013 | Q1 2018 | 3 |
KIDS | ORTHOPEDIATRICS CORP | 3 | 3 | 0.04% | 0.08% | 0.10% | Q4 2017 | Q2 2018 | 3 |
QCOR | QUESTCOR PHARMACEUTICA... | 3 | 3 | 0.04% | 0.07% | 0.11% | Q4 2013 | Q2 2014 | 3 |
EYPT | EYEPOINT PHARMACEUTICA... | 3 | 3 | 0.03% | 0.07% | 0.14% | Q2 2022 | Q4 2022 | 3 |
ECOR | ELECTROCORE INC | 3 | 3 | 0.05% | 0.06% | 0.08% | Q2 2018 | Q4 2018 | 3 |
PTGX | PROTAGONIST THERAPEUTI... | 2 | 1 | 0.01% | 0.05% | 0.14% | Q4 2019 | Q1 2023 | 3 |
FIELD TRIP HEALTH LTD | 3 | 3 | 0.01% | 0.05% | 0.08% | Q3 2021 | Q1 2022 | 3 | |
APLS | APELLIS PHARMACEUTICAL... | 2 | 1 | 0.02% | 0.04% | 0.06% | Q1 2019 | Q3 2023 | 3 |
GLUE | MONTE ROSA THERAPEUTIC... | 2 | 1 | 0.00% | 0.03% | 0.08% | Q2 2021 | Q4 2022 | 3 |
CABA | CABALETTA BIO INC | 3 | 3 | 0.02% | 0.02% | 0.04% | Q3 2021 | Q1 2022 | 3 |
CEMP | CEMPRA INC | 3 | 3 | 0.01% | 0.01% | 0.02% | Q4 2014 | Q2 2015 | 3 |
CHDX | CHINDEX INTERNATIONAL INC | 3 | 3 | 0.01% | 0.01% | 0.01% | Q2 2013 | Q4 2013 | 3 |
ALT | ALTIMMUNE INC | 3 | 3 | 0.00% | 0.01% | 0.01% | Q1 2023 | Q3 2023 | 3 |
PPBT | PURPLE BIOTECH LTD | 3 | 3 | 0.00% | 0.00% | 0.01% | Q4 2020 | Q2 2021 | 3 |
ARLZ | ARALEZ PHARMACEUTICALS... | 3 | 3 | 0.00% | 0.00% | 0.00% | Q2 2016 | Q4 2016 | 3 |
ACELYRIN INC | 2 | 2 | 1.15% | 1.58% | 2.02% | Q2 2023 | Q3 2023 | 2 | |
ACT | ACTAVIS INC | 2 | 2 | 1.22% | 1.48% | 1.75% | Q2 2013 | Q3 2013 | 2 |
WCRX | WARNER CHILCOTT PLC IR... | 2 | 2 | 1.00% | 1.08% | 1.16% | Q2 2013 | Q3 2013 | 2 |
MDGL | MADRIGAL PHARMACEUTICA... | 2 | 2 | 0.79% | 1.07% | 1.35% | Q2 2023 | Q3 2023 | 2 |
ALGN | ALIGN TECHNOLOGY INC | 2 | 2 | 0.65% | 0.65% | 0.66% | Q2 2013 | Q3 2013 | 2 |
CHNG | CHANGE HEALTHCARE INC | 2 | 2 | 0.50% | 0.53% | 0.56% | Q3 2020 | Q4 2020 | 2 |
CDNA | CAREDX INC | 2 | 2 | 0.40% | 0.43% | 0.46% | Q1 2019 | Q2 2019 | 2 |
CYTEK BIOSCIENCES INC | 2 | 2 | 0.40% | 0.43% | 0.45% | Q3 2021 | Q4 2021 | 2 | |
SPPI | SPECTRUM PHARMACEUTICA... | 2 | 2 | 0.37% | 0.41% | 0.46% | Q3 2018 | Q4 2018 | 2 |
LPNT | LIFEPOINT HEALTH INC | 2 | 2 | 0.30% | 0.41% | 0.53% | Q1 2018 | Q2 2018 | 2 |
GNFT | GENFIT S A | 2 | 2 | 0.34% | 0.40% | 0.46% | Q1 2019 | Q2 2019 | 2 |
ACT | ACTAVIS INC | 2 | 2 | 0.38% | 0.38% | 0.38% | Q2 2013 | Q3 2013 | 2 |
Q | QUINTILES TRANSNATIO H... | 2 | 2 | 0.35% | 0.37% | 0.40% | Q2 2013 | Q3 2013 | 2 |
CMRX | CHIMERIX INC | 2 | 2 | 0.35% | 0.37% | 0.39% | Q2 2015 | Q3 2015 | 2 |
KYTH | KYTHERA BIOPHARMACEUTI... | 2 | 2 | 0.24% | 0.32% | 0.41% | Q4 2014 | Q1 2015 | 2 |
CINCOR PHARMA INC | 2 | 2 | 0.19% | 0.32% | 0.45% | Q3 2022 | Q4 2022 | 2 | |
BFYT | BENEFYTT TECHNOLOGIES INC | 2 | 2 | 0.28% | 0.32% | 0.36% | Q1 2020 | Q2 2020 | 2 |
TAK | TAKEDA PHARMACEUTICAL ... | 2 | 2 | 0.27% | 0.29% | 0.32% | Q1 2019 | Q2 2019 | 2 |
VRTX | VERTEX PHARMACEUTICALS... | 2 | 2 | 0.23% | 0.29% | 0.36% | Q2 2018 | Q3 2018 | 2 |
AKRO | AKERO THERAPEUTICS INC | 2 | 2 | 0.17% | 0.27% | 0.38% | Q2 2023 | Q3 2023 | 2 |
PRGO | PERRIGO CO | 2 | 2 | 0.15% | 0.27% | 0.40% | Q3 2013 | Q4 2013 | 2 |
A | AGILENT TECHNOLOGIES INC | 2 | 2 | 0.26% | 0.26% | 0.27% | Q2 2013 | Q3 2013 | 2 |
BAX | BAXTER INTL INC | 2 | 2 | 0.25% | 0.26% | 0.28% | Q1 2023 | Q2 2023 | 2 |
F113PS | COVIDIEN PLC | 2 | 2 | 0.23% | 0.24% | 0.24% | Q3 2014 | Q4 2014 | 2 |
VERASTEM INC | 2 | 2 | 0.21% | 0.24% | 0.26% | Q2 2023 | Q3 2023 | 2 | |
HUM | HUMANA INC | 1 | 1 | 0.20% | 0.23% | 0.26% | Q4 2016 | Q2 2023 | 2 |
IBB | ISHARES TR | 2 | 2 | 0.14% | 0.22% | 0.31% | Q1 2016 | Q2 2016 | 2 |
ITCI | INTRA CELLULAR THERAPI... | 2 | 2 | 0.09% | 0.22% | 0.36% | Q1 2016 | Q2 2016 | 2 |
BMRN | BIOMARIN PHARMACEUTICA... | 2 | 2 | 0.10% | 0.22% | 0.34% | Q1 2019 | Q2 2019 | 2 |
DYAX | DYAX CORP | 2 | 2 | 0.22% | 0.22% | 0.22% | Q2 2015 | Q3 2015 | 2 |
KTWO | K2M GROUP HLDGS INC | 2 | 2 | 0.20% | 0.21% | 0.23% | Q1 2018 | Q2 2018 | 2 |
JAZZ | JAZZ PHARMACEUTICALS PLC | 1 | 1 | 0.16% | 0.21% | 0.26% | Q2 2014 | Q2 2017 | 2 |
DNDNQ | DENDREON CORP | 2 | 2 | 0.04% | 0.20% | 0.36% | Q2 2013 | Q3 2013 | 2 |
DVAX | DYNAVAX TECHNOLOGIES CORP | 2 | 2 | 0.19% | 0.20% | 0.21% | Q2 2013 | Q3 2013 | 2 |
ACIU | AC IMMUNE SA | 2 | 2 | 0.14% | 0.20% | 0.25% | Q3 2018 | Q4 2018 | 2 |
RETA | REATA PHARMACEUTICALS INC | 2 | 2 | 0.15% | 0.19% | 0.23% | Q2 2019 | Q3 2019 | 2 |
XLV | SELECT SECTOR SPDR TR | 2 | 2 | 0.16% | 0.17% | 0.17% | Q4 2019 | Q1 2020 | 2 |
NLTX | NEOLEUKIN THERAPEUTICS... | 2 | 2 | 0.16% | 0.17% | 0.18% | Q4 2019 | Q1 2020 | 2 |
MOH | MOLINA HEALTHCARE INC | 1 | 1 | 0.14% | 0.16% | 0.18% | Q3 2013 | Q2 2016 | 2 |
GTS | TRIPLE-S MGMT CORP | 2 | 2 | 0.14% | 0.16% | 0.18% | Q1 2018 | Q2 2018 | 2 |
MORF | MORPHIC HLDG INC | 2 | 2 | 0.10% | 0.16% | 0.22% | Q2 2023 | Q3 2023 | 2 |
CELG | CELGENE CORP | 1 | 1 | 0.12% | 0.16% | 0.20% | Q4 2017 | Q4 2018 | 2 |
XBI | SPDR SER TR | 1 | 1 | 0.15% | 0.15% | 0.15% | Q4 2019 | Q1 2023 | 2 |
VNDA | VANDA PHARMACEUTICALS INC | 2 | 2 | 0.14% | 0.15% | 0.15% | Q3 2016 | Q4 2016 | 2 |
HNT | HEALTH NET INC | 1 | 1 | 0.14% | 0.15% | 0.15% | Q3 2013 | Q3 2015 | 2 |
PFNX | PFENEX INC | 2 | 2 | 0.10% | 0.14% | 0.19% | Q4 2019 | Q1 2020 | 2 |
ALLK | ALLAKOS INC | 2 | 2 | 0.11% | 0.14% | 0.17% | Q3 2018 | Q4 2018 | 2 |
BSX | BOSTON SCIENTIFIC CORP | 1 | 1 | 0.11% | 0.14% | 0.16% | Q4 2018 | Q2 2021 | 2 |
MOONLAKE IMMUNOTHERAPE... | 2 | 2 | 0.11% | 0.12% | 0.14% | Q2 2023 | Q3 2023 | 2 | |
MAPS | WM TECHNOLOGY INC | 2 | 2 | 0.11% | 0.12% | 0.13% | Q2 2021 | Q3 2021 | 2 |
ALBO | ALBIREO PHARMA INC | 1 | 1 | 0.09% | 0.12% | 0.14% | Q3 2020 | Q1 2022 | 2 |
RCUS | ARCUS BIOSCIENCES INC | 1 | 1 | 0.08% | 0.11% | 0.15% | Q2 2020 | Q3 2022 | 2 |
AGIO | AGIOS PHARMACEUTICALS INC | 2 | 2 | 0.08% | 0.11% | 0.15% | Q1 2020 | Q2 2020 | 2 |
TXG | 10X GENOMICS INC | 2 | 2 | 0.10% | 0.11% | 0.12% | Q1 2020 | Q2 2020 | 2 |
NSPR | INSPIREMD INC | 2 | 2 | 0.08% | 0.11% | 0.13% | Q2 2023 | Q3 2023 | 2 |
CNVY | CONVEY HLDG PARENT INC | 2 | 2 | 0.09% | 0.10% | 0.12% | Q2 2021 | Q3 2021 | 2 |
MRTX | MIRATI THERAPEUTICS INC | 1 | 1 | 0.09% | 0.10% | 0.11% | Q1 2023 | Q3 2023 | 2 |
HZNP | HORIZON THERAPEUTICS P... | 2 | 2 | 0.09% | 0.10% | 0.11% | Q1 2023 | Q2 2023 | 2 |
NTRA | NATERA INC | 2 | 2 | 0.10% | 0.10% | 0.10% | Q1 2022 | Q2 2022 | 2 |
AEGR | AEGERION PHARMACEUTICA... | 1 | 1 | 0.08% | 0.10% | 0.11% | Q1 2014 | Q4 2014 | 2 |
AEGR | AEGERION PHARMACEUTICA... | 1 | 1 | 0.08% | 0.10% | 0.11% | Q3 2013 | Q1 2014 | 2 |
CUTR | CUTERA INC | 2 | 2 | 0.08% | 0.09% | 0.11% | Q2 2023 | Q3 2023 | 2 |
IMVT | IMMUNOVANT INC | 2 | 2 | 0.05% | 0.08% | 0.12% | Q1 2020 | Q2 2020 | 2 |
RGNX | REGENXBIO INC | 2 | 2 | 0.02% | 0.08% | 0.15% | Q4 2019 | Q1 2020 | 2 |
IGMS | IGM BIOSCIENCES INC | 2 | 2 | 0.08% | 0.08% | 0.08% | Q1 2020 | Q2 2020 | 2 |
AADI BIOSCIENCES INC | 2 | 2 | 0.04% | 0.08% | 0.11% | Q3 2021 | Q4 2021 | 2 | |
IMCR | IMMUNOCORE HLDGS PLC | 2 | 2 | 0.06% | 0.08% | 0.09% | Q1 2022 | Q2 2022 | 2 |
ASPX | AUSPEX PHARMACEUTICALS... | 2 | 2 | 0.05% | 0.07% | 0.10% | Q4 2014 | Q1 2015 | 2 |
ARRAY BIOPHARMA INC | 2 | 2 | 0.05% | 0.07% | 0.10% | Q2 2013 | Q3 2013 | 2 | |
OM | OUTSET MED INC | 2 | 2 | 0.06% | 0.07% | 0.08% | Q3 2020 | Q4 2020 | 2 |
YI | 111 INC | 2 | 2 | 0.06% | 0.07% | 0.08% | Q3 2018 | Q4 2018 | 2 |
HZNP | HORIZON PHARMA INC | 2 | 2 | 0.04% | 0.07% | 0.10% | Q1 2014 | Q2 2014 | 2 |
CELGZ | CELGENE CORP | 2 | 2 | 0.05% | 0.06% | 0.08% | Q2 2013 | Q3 2013 | 2 |
VTAE | VITAE PHARMACEUTICALS INC | 2 | 2 | 0.04% | 0.06% | 0.08% | Q3 2015 | Q4 2015 | 2 |
AMRX | AMNEAL PHARMACEUTICALS... | 2 | 2 | 0.06% | 0.06% | 0.06% | Q3 2022 | Q4 2022 | 2 |
TCRR | TCR2 THERAPEUTICS INC | 2 | 2 | 0.05% | 0.06% | 0.07% | Q4 2020 | Q1 2021 | 2 |
CSII | CARDIOVASCULAR SYS INC... | 2 | 2 | 0.04% | 0.06% | 0.08% | Q2 2014 | Q3 2014 | 2 |
RMED | RA MED SYS INC | 2 | 2 | 0.05% | 0.06% | 0.07% | Q3 2018 | Q4 2018 | 2 |
STIM | NEURONETICS INC | 2 | 2 | 0.05% | 0.05% | 0.06% | Q2 2018 | Q3 2018 | 2 |
SURF | SURFACE ONCOLOGY INC | 2 | 2 | 0.03% | 0.05% | 0.08% | Q3 2021 | Q4 2021 | 2 |
MDCO | MEDICINES CO | 1 | 1 | 0.02% | 0.05% | 0.09% | Q4 2018 | Q2 2019 | 2 |
HALO | HALOZYME THERAPEUTICS INC | 2 | 2 | 0.05% | 0.05% | 0.06% | Q2 2017 | Q3 2017 | 2 |
RNA | AVIDITY BIOSCIENCES INC | 2 | 2 | 0.02% | 0.05% | 0.08% | Q2 2020 | Q3 2020 | 2 |
CLVS | CLOVIS ONCOLOGY INC | 2 | 2 | 0.04% | 0.05% | 0.05% | Q1 2018 | Q2 2018 | 2 |
ARRY | ARRAY BIOPHARMA INC | 2 | 2 | 0.03% | 0.05% | 0.07% | Q1 2015 | Q2 2015 | 2 |
GLYC | GLYCOMIMETICS INC | 2 | 2 | 0.04% | 0.04% | 0.04% | Q2 2017 | Q3 2017 | 2 |
RVNC | REVANCE THERAPEUTICS INC | 2 | 2 | 0.03% | 0.04% | 0.05% | Q1 2023 | Q2 2023 | 2 |
CALT | CALLIDITAS THERAPEUTIC... | 2 | 2 | 0.01% | 0.04% | 0.07% | Q2 2020 | Q3 2020 | 2 |
ANGO | ANGIODYNAMICS INC | 2 | 2 | 0.04% | 0.04% | 0.04% | Q1 2014 | Q2 2014 | 2 |
KTOV | KITOV PHARMA LTD | 2 | 2 | 0.02% | 0.04% | 0.05% | Q1 2020 | Q2 2020 | 2 |
SGMO | SANGAMO BIOSCIENCES INC | 2 | 2 | 0.03% | 0.04% | 0.04% | Q3 2016 | Q4 2016 | 2 |
PERNIX THERAPEUTICS HL... | 2 | 2 | 0.03% | 0.03% | 0.04% | Q2 2016 | Q3 2016 | 2 | |
ELEV | ELEVATION ONCOLOGY INC | 2 | 2 | 0.02% | 0.03% | 0.04% | Q2 2023 | Q3 2023 | 2 |
CLSD | CLEARSIDE BIOMEDICAL INC | 2 | 2 | 0.03% | 0.03% | 0.03% | Q4 2016 | Q1 2017 | 2 |
EXSCIENTIA PLC | 2 | 2 | 0.03% | 0.03% | 0.03% | Q4 2021 | Q1 2022 | 2 | |
AKRXQ | AKORN INC | 1 | 1 | 0.02% | 0.03% | 0.04% | Q1 2015 | Q2 2018 | 2 |
DRNA | DICERNA PHARMACEUTICAL... | 2 | 2 | 0.02% | 0.03% | 0.04% | Q1 2015 | Q2 2015 | 2 |
CERS | CERUS CORP | 2 | 2 | 0.02% | 0.03% | 0.03% | Q1 2014 | Q2 2014 | 2 |
ADMS | ADAMAS PHARMACEUTICALS... | 1 | 1 | 0.02% | 0.02% | 0.03% | Q2 2018 | Q4 2018 | 2 |
OCUL | OCULAR THERAPEUTIX INC | 2 | 2 | 0.01% | 0.02% | 0.03% | Q3 2015 | Q4 2015 | 2 |
CALCIMEDICA INC | 2 | 2 | 0.02% | 0.02% | 0.02% | Q2 2023 | Q3 2023 | 2 | |
CVM | CEL-SCI CORP | 1 | 1 | 0.01% | 0.02% | 0.02% | Q3 2019 | Q1 2021 | 2 |
MRSN | MERSANA THERAPEUTICS INC | 2 | 2 | 0.02% | 0.02% | 0.02% | Q1 2023 | Q2 2023 | 2 |
EXAS | EXACT SCIENCES CORP | 2 | 2 | 0.02% | 0.02% | 0.02% | Q4 2013 | Q1 2014 | 2 |
RUBY | RUBIUS THERAPEUTICS INC | 2 | 2 | 0.01% | 0.01% | 0.02% | Q3 2019 | Q4 2019 | 2 |
VTL | VITAL THERAPIES INC | 2 | 2 | 0.01% | 0.01% | 0.02% | Q1 2015 | Q2 2015 | 2 |
ZFGN | ZAFGEN INC | 2 | 2 | 0.01% | 0.01% | 0.01% | Q4 2019 | Q1 2020 | 2 |
MBIO | MUSTANG BIO INC | 2 | 2 | 0.01% | 0.01% | 0.02% | Q4 2019 | Q1 2020 | 2 |
MAPSW | WM TECHNOLOGY INC | 2 | 2 | 0.01% | 0.01% | 0.01% | Q2 2021 | Q3 2021 | 2 |
ZGNX | ZOGENIX INC | 2 | 2 | 0.01% | 0.01% | 0.01% | Q1 2014 | Q2 2014 | 2 |
NKTR | NEKTAR THERAPEUTICS | 2 | 2 | 0.01% | 0.01% | 0.01% | Q1 2023 | Q2 2023 | 2 |
ALIM | ALIMERA SCIENCES INC | 2 | 2 | 0.00% | 0.00% | 0.00% | Q3 2015 | Q4 2015 | 2 |
OWLET INC | 2 | 2 | 0.00% | 0.00% | 0.00% | Q4 2021 | Q1 2022 | 2 | |
ONXX | ONYX PHARMACEUTICALS INC | 1 | 1 | 2.16% | 2.16% | 2.16% | Q2 2013 | Q2 2013 | 1 |
ARMO | ARMO BIOSCIENCES INC | 1 | 1 | 1.91% | 1.91% | 1.91% | Q1 2018 | Q1 2018 | 1 |
PRGO | PERRIGO CO | 1 | 1 | 1.74% | 1.74% | 1.74% | Q4 2013 | Q4 2013 | 1 |
DHR | DANAHER CORPORATION | 1 | 1 | 1.40% | 1.40% | 1.40% | Q4 2019 | Q4 2019 | 1 |
B108PS | ACTAVIS PLC | 1 | 1 | 1.27% | 1.27% | 1.27% | Q1 2015 | Q1 2015 | 1 |
RAYZEBIO INC | 1 | 1 | 1.24% | 1.24% | 1.24% | Q3 2023 | Q3 2023 | 1 | |
CVS | CVS HEALTH CORP | 1 | 1 | 0.96% | 0.96% | 0.96% | Q4 2018 | Q4 2018 | 1 |
ACTPRA | ACTAVIS PLC | 1 | 1 | 0.90% | 0.90% | 0.90% | Q1 2015 | Q1 2015 | 1 |
SPY | SPDR S&P 500 ETF TR | 1 | 1 | 0.90% | 0.90% | 0.90% | Q3 2013 | Q3 2013 | 1 |
HAE | HAEMONETICS CORP MASS | 1 | 1 | 0.88% | 0.88% | 0.88% | Q1 2021 | Q1 2021 | 1 |
ICLR | ICON PLC | 1 | 1 | 0.69% | 0.69% | 0.69% | Q3 2023 | Q3 2023 | 1 |
APOGEE THERAPEUTICS INC | 1 | 1 | 0.65% | 0.65% | 0.65% | Q3 2023 | Q3 2023 | 1 | |
WCG | WELLCARE HEALTH PLANS INC | 1 | 1 | 0.59% | 0.59% | 0.59% | Q2 2013 | Q2 2013 | 1 |
MAKO | MAKO SURGICAL CORP | 1 | 1 | 0.56% | 0.56% | 0.56% | Q2 2013 | Q2 2013 | 1 |
XBI | SPDR SERIES TRUST | 1 | 1 | 0.55% | 0.55% | 0.55% | Q2 2013 | Q2 2013 | 1 |
AMYLYX PHARMACEUTICALS... | 1 | 1 | 0.47% | 0.47% | 0.47% | Q1 2023 | Q1 2023 | 1 | |
MEDTRONIC PLC | 1 | 1 | 0.46% | 0.46% | 0.46% | Q1 2015 | Q1 2015 | 1 | |
NEUMORA THERAPEUTICS INC. | 1 | 1 | 0.45% | 0.45% | 0.45% | Q3 2023 | Q3 2023 | 1 | |
SLQT | SELECTQUOTE INC | 1 | 1 | 0.45% | 0.45% | 0.45% | Q2 2020 | Q2 2020 | 1 |
NTUS | NATUS MEDICAL INC DEL | 1 | 1 | 0.41% | 0.41% | 0.41% | Q2 2013 | Q2 2013 | 1 |
WCRX | WARNER CHILCOTT PLC IR... | 1 | 1 | 0.41% | 0.41% | 0.41% | Q2 2013 | Q2 2013 | 1 |
CBAY | CYMABAY THERAPEUTICS INC | 1 | 1 | 0.38% | 0.38% | 0.38% | Q1 2019 | Q1 2019 | 1 |
SLXP | SALIX PHARMACEUTICALS INC | 1 | 1 | 0.33% | 0.33% | 0.33% | Q3 2014 | Q3 2014 | 1 |
COO | COOPER COS INC | 1 | 1 | 0.32% | 0.32% | 0.32% | Q3 2014 | Q3 2014 | 1 |
SQNM | SEQUENOM INC | 1 | 1 | 0.32% | 0.32% | 0.32% | Q2 2013 | Q2 2013 | 1 |
AMGN | AMGEN INC | 1 | 1 | 0.29% | 0.29% | 0.29% | Q3 2014 | Q3 2014 | 1 |
MRNA | MODERNA INC | 1 | 1 | 0.28% | 0.28% | 0.28% | Q4 2022 | Q4 2022 | 1 |
ASTX | ASTEX PHARMACEUTICALS INC | 1 | 1 | 0.28% | 0.28% | 0.28% | Q2 2013 | Q2 2013 | 1 |
AVTR | AVANTOR INC | 1 | 1 | 0.26% | 0.26% | 0.26% | Q4 2019 | Q4 2019 | 1 |
HITK | HI-TECH PHARMACAL INC | 1 | 1 | 0.26% | 0.26% | 0.26% | Q2 2013 | Q2 2013 | 1 |
TURNSTONE BIOLOGICS CORP | 1 | 1 | 0.26% | 0.26% | 0.26% | Q3 2023 | Q3 2023 | 1 | |
ONXX | ONYX PHARMACEUTICALS INC | 1 | 1 | 0.25% | 0.25% | 0.25% | Q3 2013 | Q3 2013 | 1 |
MRK | MERCK & CO INC | 1 | 1 | 0.25% | 0.25% | 0.25% | Q3 2016 | Q3 2016 | 1 |
ZIOP | ZIOPHARM ONCOLOGY INC | 1 | 1 | 0.23% | 0.23% | 0.23% | Q1 2015 | Q1 2015 | 1 |
INCY | INCYTE CORP | 1 | 1 | 0.22% | 0.22% | 0.22% | Q3 2017 | Q3 2017 | 1 |
HUMACYTE INC | 1 | 1 | 0.19% | 0.19% | 0.19% | Q3 2021 | Q3 2021 | 1 | |
IMMUNOGEN INC | 1 | 1 | 0.19% | 0.19% | 0.19% | Q2 2017 | Q2 2017 | 1 | |
ECYT | ENDOCYTE INC | 1 | 1 | 0.18% | 0.18% | 0.18% | Q2 2013 | Q2 2013 | 1 |
VPHM | VIROPHARMA INC | 1 | 1 | 0.18% | 0.18% | 0.18% | Q3 2013 | Q3 2013 | 1 |
RARX | RA PHARMACEUTICALS INC | 1 | 1 | 0.17% | 0.17% | 0.17% | Q3 2019 | Q3 2019 | 1 |
PFE | PFIZER INC | 1 | 1 | 0.17% | 0.17% | 0.17% | Q2 2019 | Q2 2019 | 1 |
ALHC | ALIGNMENT HEALTHCARE INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q1 2021 | Q1 2021 | 1 |
OPTR | OPTIMER PHARMACEUTICAL... | 1 | 1 | 0.16% | 0.16% | 0.16% | Q2 2013 | Q2 2013 | 1 |
INO | INOVIO PHARMACEUTICALS... | 1 | 1 | 0.16% | 0.16% | 0.16% | Q1 2014 | Q1 2014 | 1 |
ILMN | ILLUMINA INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q4 2013 | Q4 2013 | 1 |
DICE THERAPEUTICS INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q3 2021 | Q3 2021 | 1 | |
GNMK | GENMARK DIAGNOSTICS INC | 1 | 1 | 0.15% | 0.15% | 0.15% | Q2 2020 | Q2 2020 | 1 |
ELN | ELAN PLC | 1 | 1 | 0.15% | 0.15% | 0.15% | Q2 2013 | Q2 2013 | 1 |
THC | TENET HEALTHCARE CORP | 1 | 1 | 0.15% | 0.15% | 0.15% | Q2 2023 | Q2 2023 | 1 |
SHPG | SHIRE PLC | 1 | 1 | 0.15% | 0.15% | 0.15% | Q3 2017 | Q3 2017 | 1 |
ANNX | ANNEXON INC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q3 2020 | Q3 2020 | 1 |
AVNR | AVANIR PHARMACEUTICALS... | 1 | 1 | 0.14% | 0.14% | 0.14% | Q3 2013 | Q3 2013 | 1 |
QCOR | QUESTCOR PHARMACEUTICA... | 1 | 1 | 0.14% | 0.14% | 0.14% | Q2 2014 | Q2 2014 | 1 |
SGEN | SEATTLE GENETICS INC | 1 | 1 | 0.13% | 0.13% | 0.13% | Q2 2013 | Q2 2013 | 1 |
KENVUE INC | 1 | 1 | 0.13% | 0.13% | 0.13% | Q3 2023 | Q3 2023 | 1 | |
CARA | CARA THERAPEUTICS INC | 1 | 1 | 0.13% | 0.13% | 0.13% | Q1 2020 | Q1 2020 | 1 |
FRX | FOREST LABS INC | 1 | 1 | 0.13% | 0.13% | 0.13% | Q4 2013 | Q4 2013 | 1 |
MYL | MYLAN N V | 1 | 1 | 0.13% | 0.13% | 0.13% | Q1 2018 | Q1 2018 | 1 |
EHTH | EHEALTH INC | 1 | 1 | 0.13% | 0.13% | 0.13% | Q3 2019 | Q3 2019 | 1 |
ALDR | ALDER BIOPHARMACEUTICA... | 1 | 1 | 0.12% | 0.12% | 0.12% | Q3 2019 | Q3 2019 | 1 |
CFN | CAREFUSION CORP | 1 | 1 | 0.12% | 0.12% | 0.12% | Q1 2014 | Q1 2014 | 1 |
PRAX | PRAXIS PRECISION MEDIC... | 1 | 1 | 0.12% | 0.12% | 0.12% | Q4 2020 | Q4 2020 | 1 |
BMY | BRISTOL MYERS SQUIBB CO | 1 | 1 | 0.12% | 0.12% | 0.12% | Q1 2017 | Q1 2017 | 1 |
ICPT | INTERCEPT PHARMACEUTIC... | 1 | 1 | 0.12% | 0.12% | 0.12% | Q4 2018 | Q4 2018 | 1 |
NVO | NOVO-NORDISK A S | 1 | 1 | 0.12% | 0.12% | 0.12% | Q1 2018 | Q1 2018 | 1 |
SSPK | SILVER SPIKE ACQUISITI... | 1 | 1 | 0.12% | 0.12% | 0.12% | Q1 2021 | Q1 2021 | 1 |
HORIZON PHARMA INVT LTD | 1 | 1 | 0.12% | 0.12% | 0.12% | Q1 2016 | Q1 2016 | 1 | |
MYL | MYLAN N V | 1 | 1 | 0.11% | 0.11% | 0.11% | Q1 2015 | Q1 2015 | 1 |
AMRN | AMARIN CORP PLC | 1 | 1 | 0.11% | 0.11% | 0.11% | Q1 2019 | Q1 2019 | 1 |
PCVX | VAXCYTE INC | 1 | 1 | 0.11% | 0.11% | 0.11% | Q3 2022 | Q3 2022 | 1 |
RVMD | REVOLUTION MEDICINES INC | 1 | 1 | 0.11% | 0.11% | 0.11% | Q1 2020 | Q1 2020 | 1 |
WVE | WAVE LIFE SCIENCES LTD | 1 | 1 | 0.11% | 0.11% | 0.11% | Q1 2019 | Q1 2019 | 1 |
OREXIGEN THERAPEUTICS INC | 1 | 1 | 0.11% | 0.11% | 0.11% | Q4 2013 | Q4 2013 | 1 | |
KENVUE INC | 1 | 1 | 0.11% | 0.11% | 0.11% | Q3 2023 | Q3 2023 | 1 | |
GILD | GILEAD SCIENCES INC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q2 2019 | Q2 2019 | 1 |
BNTX | BIONTECH SE | 1 | 1 | 0.10% | 0.10% | 0.10% | Q4 2022 | Q4 2022 | 1 |
CVAC | CUREVAC N V | 1 | 1 | 0.10% | 0.10% | 0.10% | Q2 2021 | Q2 2021 | 1 |
STJ | ST JUDE MED INC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q2 2014 | Q2 2014 | 1 |
OLK | OLINK HLDG AB | 1 | 1 | 0.10% | 0.10% | 0.10% | Q1 2021 | Q1 2021 | 1 |
DXCM | DEXCOM INC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q3 2023 | Q3 2023 | 1 |
DENDREON CORP | 1 | 1 | 0.10% | 0.10% | 0.10% | Q2 2013 | Q2 2013 | 1 | |
GOSS | GOSSAMER BIO INC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q4 2021 | Q4 2021 | 1 |
AAVL | AVALANCHE BIOTECHNOLOG... | 1 | 1 | 0.10% | 0.10% | 0.10% | Q1 2015 | Q1 2015 | 1 |
PRGO | PERRIGO CO PLC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q1 2014 | Q1 2014 | 1 |
MNKKQ | MALLINCKRODT PUB LTD CO | 1 | 1 | 0.09% | 0.09% | 0.09% | Q2 2017 | Q2 2017 | 1 |
SNY | SANOFI | 1 | 1 | 0.09% | 0.09% | 0.09% | Q4 2022 | Q4 2022 | 1 |
ZGNX | ZOGENIX INC | 1 | 1 | 0.09% | 0.09% | 0.09% | Q4 2019 | Q4 2019 | 1 |
ADPT | ADAPTIVE BIOTECHNOLOGI... | 1 | 1 | 0.09% | 0.09% | 0.09% | Q2 2019 | Q2 2019 | 1 |
AZN | ASTRAZENECA PLC | 1 | 1 | 0.09% | 0.09% | 0.09% | Q2 2017 | Q2 2017 | 1 |
VTRS | VIATRIS INC | 1 | 1 | 0.09% | 0.09% | 0.09% | Q4 2020 | Q4 2020 | 1 |
ENDP | ENDO HEALTH SOLUTIONS INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q3 2013 | Q3 2013 | 1 |
EVH | EVOLENT HEALTH INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q3 2021 | Q3 2021 | 1 |
VRTX | VERTEX PHARMACEUTICALS... | 1 | 1 | 0.08% | 0.08% | 0.08% | Q1 2014 | Q1 2014 | 1 |
MCK | MCKESSON CORP | 1 | 1 | 0.08% | 0.08% | 0.08% | Q3 2018 | Q3 2018 | 1 |
BMRN | BIOMARIN PHARMACEUTICA... | 1 | 1 | 0.08% | 0.08% | 0.08% | Q2 2018 | Q2 2018 | 1 |
NUVB | NUVATION BIO INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q1 2021 | Q1 2021 | 1 |
AFFYMETRIX INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q2 2013 | Q2 2013 | 1 | |
RPTP | RAPTOR PHARMACEUTICAL ... | 1 | 1 | 0.07% | 0.07% | 0.07% | Q1 2014 | Q1 2014 | 1 |
OWLET INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q3 2021 | Q3 2021 | 1 | |
ANTH | ANTHERA PHARMACEUTICAL... | 1 | 1 | 0.07% | 0.07% | 0.07% | Q2 2013 | Q2 2013 | 1 |
NVAX | NOVAVAX INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q2 2022 | Q2 2022 | 1 |
VPHM | VIROPHARMA INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q3 2013 | Q3 2013 | 1 |
GILD | GILEAD SCIENCES INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q1 2014 | Q1 2014 | 1 |
COGT | COGENT BIOSCIENCES INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q4 2020 | Q4 2020 | 1 |
MYOV | MYOVANT SCIENCES LTD | 1 | 1 | 0.06% | 0.06% | 0.06% | Q3 2020 | Q3 2020 | 1 |
TEVA | TEVA PHARMACEUTICAL IN... | 1 | 1 | 0.06% | 0.06% | 0.06% | Q2 2014 | Q2 2014 | 1 |
RGLS | REGULUS THERAPEUTICS INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q4 2014 | Q4 2014 | 1 |
DNDNQ | DENDREON CORP | 1 | 1 | 0.06% | 0.06% | 0.06% | Q2 2013 | Q2 2013 | 1 |
VERV | VERVE THERAPEUTICS INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q2 2021 | Q2 2021 | 1 |
CTRX | CATAMARAN CORP | 1 | 1 | 0.06% | 0.06% | 0.06% | Q1 2015 | Q1 2015 | 1 |
NVRO | NEVRO CORP | 1 | 1 | 0.06% | 0.06% | 0.06% | Q2 2017 | Q2 2017 | 1 |
STOK | STOKE THERAPEUTICS INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q2 2019 | Q2 2019 | 1 |
PROCEPT BIOROBOTICS CORP | 1 | 1 | 0.06% | 0.06% | 0.06% | Q3 2021 | Q3 2021 | 1 | |
DERM | DERMIRA INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q4 2019 | Q4 2019 | 1 |
MDVN | MEDIVATION INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q3 2013 | Q3 2013 | 1 |
INCY | INCYTE CORP | 1 | 1 | 0.05% | 0.05% | 0.05% | Q4 2013 | Q4 2013 | 1 |
HSP | HOSPIRA INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q4 2013 | Q4 2013 | 1 |
OGN | ORGANON & CO | 1 | 1 | 0.05% | 0.05% | 0.05% | Q2 2021 | Q2 2021 | 1 |
KRTX | KARUNA THERAPEUTICS INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q3 2023 | Q3 2023 | 1 |
AZN | ASTRAZENECA PLC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q4 2019 | Q4 2019 | 1 |
SNY | SANOFI | 1 | 1 | 0.05% | 0.05% | 0.05% | Q4 2019 | Q4 2019 | 1 |
INNV | INNOVAGE HLDG CORP | 1 | 1 | 0.05% | 0.05% | 0.05% | Q1 2021 | Q1 2021 | 1 |
ABCL | ABCELLERA BIOLOGICS INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q2 2022 | Q2 2022 | 1 |
INFI | INFINITY PHARMACEUTICA... | 1 | 1 | 0.05% | 0.05% | 0.05% | Q3 2013 | Q3 2013 | 1 |
RGEN | REPLIGEN CORP | 1 | 1 | 0.05% | 0.05% | 0.05% | Q3 2021 | Q3 2021 | 1 |
KERX | KERYX BIOPHARMACEUTICA... | 1 | 1 | 0.04% | 0.04% | 0.04% | Q3 2013 | Q3 2013 | 1 |
FDMT | 4D MOLECULAR THERAPEUT... | 1 | 1 | 0.04% | 0.04% | 0.04% | Q4 2020 | Q4 2020 | 1 |
NBSE | NEUBASE THERAPEUTICS INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q1 2020 | Q1 2020 | 1 |
TDOC | TELADOC HEALTH INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q3 2023 | Q3 2023 | 1 |
KYMR | KYMERA THERAPEUTICS INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q3 2020 | Q3 2020 | 1 |
CRBP | CORBUS PHARMACEUTICALS... | 1 | 1 | 0.04% | 0.04% | 0.04% | Q2 2020 | Q2 2020 | 1 |
EXEL | EXELIXIS INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q1 2018 | Q1 2018 | 1 |
BTAI | BIOXCEL THERAPEUTICS INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q1 2020 | Q1 2020 | 1 |
RNA | PROSENSA HLDG N V | 1 | 1 | 0.04% | 0.04% | 0.04% | Q2 2014 | Q2 2014 | 1 |
AGRX | AGILE THERAPEUTICS INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q1 2020 | Q1 2020 | 1 |
GH | GUARDANT HEALTH INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q2 2022 | Q2 2022 | 1 |
GIVN | GIVEN IMAGING | 1 | 1 | 0.04% | 0.04% | 0.04% | Q2 2013 | Q2 2013 | 1 |
IMTX | IMMATICS N.V | 1 | 1 | 0.03% | 0.03% | 0.03% | Q3 2023 | Q3 2023 | 1 |
SGEN | SEATTLE GENETICS INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q4 2014 | Q4 2014 | 1 |
AAVL | AVALANCHE BIOTECHNOLOG... | 1 | 1 | 0.03% | 0.03% | 0.03% | Q2 2015 | Q2 2015 | 1 |
SNN | SMITH & NEPHEW PLC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q1 2015 | Q1 2015 | 1 |
GBT | GLOBAL BLOOD THERAPEUT... | 1 | 1 | 0.03% | 0.03% | 0.03% | Q1 2022 | Q1 2022 | 1 |
VNDA | VANDA PHARMACEUTICALS INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q3 2013 | Q3 2013 | 1 |
BRIGHT MINDS BIOSCIENC... | 1 | 1 | 0.03% | 0.03% | 0.03% | Q4 2021 | Q4 2021 | 1 | |
IMMU | IMMUNOMEDICS INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q4 2018 | Q4 2018 | 1 |
AXSM | AXSOME THERAPEUTICS INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q1 2021 | Q1 2021 | 1 |
SNSS | SUNESIS PHARMACEUTICAL... | 1 | 1 | 0.03% | 0.03% | 0.03% | Q3 2014 | Q3 2014 | 1 |
SAVA | CASSAVA SCIENCES INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q1 2020 | Q1 2020 | 1 |
SYNLOGIC INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2023 | Q3 2023 | 1 | |
ADMS | ADAMAS PHARMACEUTICALS... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2018 | Q3 2018 | 1 |
ANAB | ANAPTYSBIO INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2018 | Q3 2018 | 1 |
ASTX | ASTEX PHARMACEUTICALS INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2013 | Q2 2013 | 1 |
CVAC | CUREVAC N V | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2021 | Q2 2021 | 1 |
INSM | INSMED INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2016 | Q2 2016 | 1 |
AUXL | AUXILIUM PHARMACEUTICA... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2013 | Q2 2013 | 1 |
TGTX | TG THERAPEUTICS INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2023 | Q2 2023 | 1 |
PTLA | PORTOLA PHARMACEUTICAL... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2016 | Q1 2016 | 1 |
MASS | 908 DEVICES INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2020 | Q4 2020 | 1 |
ESPR | ESPERION THERAPEUTICS ... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2013 | Q3 2013 | 1 |
SANA | SANA BIOTECHNOLOGY INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2021 | Q1 2021 | 1 |
KTOV | KITOV PHARMA LTD | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2020 | Q3 2020 | 1 |
PDLI | PDL BIOPHARMA INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2015 | Q2 2015 | 1 |
PTCT | PTC THERAPEUTICS INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2015 | Q2 2015 | 1 |
QLTI | QLT INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2015 | Q1 2015 | 1 |
BHVN | BIOHAVEN PHARMACTL HLD... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2018 | Q1 2018 | 1 |
MACK | MERRIMACK PHARMACEUTIC... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2022 | Q4 2022 | 1 |
ACHN | ACHILLION PHARMACEUTIC... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2016 | Q1 2016 | 1 |
ITCI | INTRA CELLULAR THERAPI... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2016 | Q3 2016 | 1 |
WX | WUXI PHARMATECH CAYMAN... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2013 | Q3 2013 | 1 |
SGYPQ | SYNERGY PHARMACEUTICAL... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2015 | Q2 2015 | 1 |
EBIO | ELEVEN BIOTHERAPEUTICS... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2015 | Q2 2015 | 1 |
SGMO | SANGAMO BIOSCIENCES INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2014 | Q4 2014 | 1 |
NKTR | NEKTAR THERAPEUTICS | 1 | 1 | 0.01% | 0.01% | 0.01% | Q1 2023 | Q1 2023 | 1 |
XENT | INTERSECT ENT INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q1 2020 | Q1 2020 | 1 |
MYGN | MYRIAD GENETICS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2013 | Q3 2013 | 1 |
CALA | CALITHERA BIOSCIENCES INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2020 | Q4 2020 | 1 |
MCRB | SERES THERAPEUTICS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2017 | Q3 2017 | 1 |
KZR | KEZAR LIFE SCIENCES INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2021 | Q3 2021 | 1 |
NVUS | NOVUS THERAPEUTICS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2020 | Q4 2020 | 1 |
SSPKW | SILVER SPIKE ACQUISITI... | 1 | 1 | 0.01% | 0.01% | 0.01% | Q1 2021 | Q1 2021 | 1 |
MR | MINDRAY MEDICAL INTL LTD | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2013 | Q2 2013 | 1 |
FOMX | FOAMIX PHARMACEUTICALS... | 1 | 1 | 0.01% | 0.01% | 0.01% | Q1 2018 | Q1 2018 | 1 |
MYOV | MYOVANT SCIENCES LTD | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2020 | Q3 2020 | 1 |
ALT | ALTIMMUNE INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q1 2023 | Q1 2023 | 1 |
GTXI | GTX INC DEL | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2013 | Q2 2013 | 1 |
ARYA | ARYA SCIENCES ACQUISIT... | 1 | 1 | 0.01% | 0.01% | 0.01% | Q1 2021 | Q1 2021 | 1 |
BIOMARIN PHARMACEUTICA... | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2014 | Q2 2014 | 1 | |
BIOMARIN PHARMACEUTICA... | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2014 | Q2 2014 | 1 | |
PHAS | PHASEBIO PHARMACEUTICA... | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2021 | Q3 2021 | 1 |
DVAX | DYNAVAX TECHNOLOGIES CORP | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2013 | Q2 2013 | 1 |
NVLS | NIVALIS THERAPEUTICS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2016 | Q3 2016 | 1 |
HARPOON THERAPEUTICS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2023 | Q3 2023 | 1 | |
AUGX | AUGMEDIX INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q4 2021 | Q4 2021 | 1 |
CATABASIS PHARMACEUTIC... | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2020 | Q1 2020 | 1 | |
OWLET INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q3 2021 | Q3 2021 | 1 | |
VSAR | VERSARTIS INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q3 2017 | Q3 2017 | 1 |
TRILLIUM THERAPEUTICS INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2021 | Q1 2021 | 1 | |
Download |
The securities at the top of the list , including BIOGEN INC, VERTEX PHARMACEUTICALS INC, and THERMO FISHER SCIENTIFIC INC, are the highest-conviction holdings of Orbimed Advisors.
The conviction is calculated by counting the number of quarters a security has been reported by Orbimed Advisors. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that Orbimed Advisors owns currently or has owned in the past.